<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl" type="text/xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="52c6ec15-62c1-4b91-8536-52a30df4db99"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>These highlights do not include all the information needed to use AIMOVIG safely and effectively. See full prescribing information for AIMOVIG. <br/>
      <br/>AIMOVIG<sup>®</sup> (erenumab-aooe) injection, for subcutaneous use <br/>Initial U.S. Approval: 2018</title>
   <effectiveTime value="20250401"/>
   <setId root="b998ed05-94b0-47fd-b28f-cddd1e128fd8"/>
   <versionNumber value="23"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id extension="039976196" root="1.3.6.1.4.1.519.1"/>
            <name>Amgen Inc</name>
            <assignedEntity>
               <assignedOrganization/>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section ID="DLDE">
               <id root="c16d2bbe-7fb2-4aae-b034-0f64dd203459"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL PRODUCT DATA ELEMENTS SECTION"/>
               <effectiveTime value="20250331"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="55513-840" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>AIMOVIG</name>
                        <formCode code="C42946" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>erenumab-aooe</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator value="70" unit="mg"/>
                              <denominator value="1" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="I5I8VB78VT" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>ERENUMAB</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="I5I8VB78VT" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>ERENUMAB</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator value="1.5" unit="mg"/>
                              <denominator value="1" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="569DQM74SC" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>ACETATE ION</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator value="73" unit="mg"/>
                              <denominator value="1" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="C151H8M554" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SUCROSE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator value="0.1" unit="mg"/>
                              <denominator value="1" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="6OZP39ZG8H" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>POLYSORBATE 80</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="1" unit="mL"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43203" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SYRINGE, GLASS"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="1" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="55513-840-01" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20180522"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C102836" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 3: Prefilled Biologic Delivery Device/System (syringe, patch, etc.)" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <asContent>
                           <quantity>
                              <numerator value="1" unit="mL"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43203" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SYRINGE, GLASS"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="2" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="55513-840-02" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="completed"/>
                                       <effectiveTime>
                                          <low value="20180522"/>
                                          <high value="20210131"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C102836" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 3: Prefilled Biologic Delivery Device/System (syringe, patch, etc.)" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="BLA761077" root="2.16.840.1.113883.3.150"/>
                           <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20180522"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="55513-841" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>AIMOVIG</name>
                        <formCode code="C42946" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>erenumab-aooe</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator value="70" unit="mg"/>
                              <denominator value="1" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="I5I8VB78VT" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>ERENUMAB</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="I5I8VB78VT" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>ERENUMAB</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator value="1.5" unit="mg"/>
                              <denominator value="1" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="569DQM74SC" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>ACETATE ION</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator value="73" unit="mg"/>
                              <denominator value="1" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="C151H8M554" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SUCROSE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator value="0.1" unit="mg"/>
                              <denominator value="1" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="6OZP39ZG8H" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>POLYSORBATE 80</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="1" unit="mL"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43203" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SYRINGE, GLASS"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="1" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="55513-841-01" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20180522"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C102836" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 3: Prefilled Biologic Delivery Device/System (syringe, patch, etc.)" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <asContent>
                           <quantity>
                              <numerator value="1" unit="mL"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43203" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SYRINGE, GLASS"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="2" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="55513-841-02" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="completed"/>
                                       <effectiveTime>
                                          <low value="20180522"/>
                                          <high value="20210131"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C102836" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 3: Prefilled Biologic Delivery Device/System (syringe, patch, etc.)" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <asContent>
                           <quantity>
                              <numerator value="1" unit="mL"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43203" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SYRINGE, GLASS"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="2" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="55513-841-00" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C96974" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20180522"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C102836" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 3: Prefilled Biologic Delivery Device/System (syringe, patch, etc.)" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="BLA761077" root="2.16.840.1.113883.3.150"/>
                           <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20180522"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="55513-843" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>AIMOVIG</name>
                        <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>erenumab-aooe</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator value="140" unit="mg"/>
                              <denominator value="1" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="I5I8VB78VT" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>ERENUMAB</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="I5I8VB78VT" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>ERENUMAB</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator value="2" unit="mg"/>
                              <denominator value="1" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="569DQM74SC" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>ACETATE ION</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator value="0.1" unit="mg"/>
                              <denominator value="1" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="6OZP39ZG8H" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>POLYSORBATE 80</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator value="65" unit="mg"/>
                              <denominator value="1" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="C151H8M554" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SUCROSE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="1" unit="mL"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43202" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SYRINGE"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="1" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="55513-843-01" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20190315"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C102836" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 3: Prefilled Biologic Delivery Device/System (syringe, patch, etc.)" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <asContent>
                           <quantity>
                              <numerator value="1" unit="mL"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43202" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SYRINGE"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="1" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="55513-843-00" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C96974" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20190315"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C102836" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 3: Prefilled Biologic Delivery Device/System (syringe, patch, etc.)" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="BLA761077" root="2.16.840.1.113883.3.150"/>
                           <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20190315"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="55513-842" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>AIMOVIG</name>
                        <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>erenumab-aooe</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator value="140" unit="mg"/>
                              <denominator value="1" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="I5I8VB78VT" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>ERENUMAB</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="I5I8VB78VT" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>ERENUMAB</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator value="2" unit="mg"/>
                              <denominator value="1" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="569DQM74SC" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>ACETATE ION</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator value="0.1" unit="mg"/>
                              <denominator value="1" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="6OZP39ZG8H" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>POLYSORBATE 80</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator value="65" unit="mg"/>
                              <denominator value="1" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="C151H8M554" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SUCROSE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="1" unit="mL"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43202" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SYRINGE"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="1" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="55513-842-01" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20190315"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C102836" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 3: Prefilled Biologic Delivery Device/System (syringe, patch, etc.)" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="BLA761077" root="2.16.840.1.113883.3.150"/>
                           <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20190315"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section>
               <id root="b35ca014-cfe7-4d6c-bb1f-5119b4899a0d"/>
               <code code="43683-2" codeSystem="2.16.840.1.113883.6.1" displayName="RECENT MAJOR CHANGES SECTION"/>
               <effectiveTime value="20250331"/>
               <excerpt>
                  <highlight>
                     <text>
                        <table width="100%" styleCode="Noautorules">
                           <col width="85%" align="left" valign="top"/>
                           <col width="15%" align="right" valign="top"/>
                           <tbody>
                              <tr>
                                 <td>Warnings and Precautions (<linkHtml href="#S5.4">5.4</linkHtml>)</td>
                                 <td>3/2025</td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="S1">
               <id root="6a54b4fd-3cc9-429a-acaa-99d6fb675535"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>1 INDICATIONS AND USAGE</title>
               <text>
                  <paragraph>AIMOVIG is indicated for the preventive treatment of migraine in adults.</paragraph>
               </text>
               <effectiveTime value="20250331"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>AIMOVIG is a calcitonin gene-related peptide receptor antagonist indicated for the preventive treatment of migraine in adults. (<linkHtml href="#S1">1</linkHtml>)</paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="S2">
               <id root="f7a1a519-a555-4c7d-9c9f-c4f97212e17b"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>2 DOSAGE AND ADMINISTRATION</title>
               <effectiveTime value="20250331"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>For subcutaneous use only (<linkHtml href="#S2.1">2.1</linkHtml>, <linkHtml href="#S2.2">2.2</linkHtml>)</item>
                           <item>Recommended dosage is 70 mg once monthly; some patients may benefit from a dosage of 140 mg once monthly (<linkHtml href="#S2.1">2.1</linkHtml>)</item>
                           <item>Administer in the abdomen, thigh, or upper arm subcutaneously (<linkHtml href="#S2.2">2.2</linkHtml>)</item>
                           <item>See Dosage and Administration for important administration instructions (<linkHtml href="#S2.2">2.2</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="S2.1">
                     <id root="e37018b9-8104-46cf-9103-e8400a04513f"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.1	Recommended Dosing</title>
                     <text>
                        <paragraph>The recommended dosage of AIMOVIG is 70 mg injected subcutaneously once monthly. Some patients may benefit from a dosage of 140 mg injected subcutaneously once monthly.</paragraph>
                        <paragraph>If a dose of AIMOVIG is missed, administer as soon as possible. Thereafter, AIMOVIG can be scheduled monthly from the date of the last dose.</paragraph>
                     </text>
                     <effectiveTime value="20250331"/>
                  </section>
               </component>
               <component>
                  <section ID="S2.2">
                     <id root="c0145310-2fc5-4178-bff1-c1023026485b"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.2	Important Administration Instructions</title>
                     <text>
                        <paragraph>AIMOVIG is for subcutaneous use only.</paragraph>
                        <paragraph>AIMOVIG is intended for patient self-administration. Prior to use, provide proper training to patients and/or caregivers on how to prepare and administer AIMOVIG using the single-dose prefilled autoinjector or single-dose prefilled syringe, including aseptic technique <content styleCode="italics">[see Instructions for Use]</content>:</paragraph>
                        <list listType="unordered">
                           <item>Prior to subcutaneous administration, allow AIMOVIG to sit at room temperature for at least 30 minutes protected from direct sunlight [see <linkHtml href="#S16.2">How Supplied/Storage and Handling (16.2)</linkHtml>]. This is important for administering the entire dose and helps minimize discomfort. Do not warm by using a heat source such as hot water or a microwave.</item>
                           <item> Do not shake the product.</item>
                           <item> Inspect visually for particulate matter and discoloration prior to administration <content styleCode="italics">[see <linkHtml href="#S3">Dosage Forms and Strengths (3)</linkHtml>]</content>. Do not use if the solution is cloudy or discolored or contains flakes or particles.</item>
                           <item> Administer AIMOVIG in the abdomen, thigh, or upper arm subcutaneously. Do not inject into areas where the skin is tender, bruised, red, or hard.</item>
                           <item> Both prefilled autoinjector and prefilled syringe are single-dose and deliver the entire contents.</item>
                        </list>
                     </text>
                     <effectiveTime value="20250331"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S3">
               <id root="b7b12b27-a747-4801-991e-ac4dce786778"/>
               <code code="43678-2" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE FORMS &amp; STRENGTHS SECTION"/>
               <title>3 DOSAGE FORMS AND STRENGTHS</title>
               <text>
                  <paragraph>AIMOVIG is a sterile, clear to opalescent, colorless to light yellow solution available as follows:</paragraph>
                  <list listType="unordered">
                     <item> Injection: 70 mg/mL in a single-dose prefilled SureClick<sup>®</sup> autoinjector</item>
                     <item> Injection: 140 mg/mL in a single-dose prefilled SureClick<sup>®</sup> autoinjector</item>
                     <item> Injection: 70 mg/mL in a single-dose prefilled syringe</item>
                     <item> Injection: 140 mg/mL in a single-dose prefilled syringe</item>
                  </list>
               </text>
               <effectiveTime value="20250331"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>Injection: 70 mg/mL solution in a single-dose prefilled SureClick<sup>®</sup> autoinjector (<linkHtml href="#S3">3</linkHtml>)</item>
                           <item>Injection: 140 mg/mL solution in a single-dose prefilled SureClick<sup>®</sup> autoinjector (<linkHtml href="#S3">3</linkHtml>)</item>
                           <item>Injection: 70 mg/mL solution in a single-dose prefilled syringe (<linkHtml href="#S3">3</linkHtml>)</item>
                           <item>Injection: 140 mg/mL solution in a single-dose prefilled syringe (<linkHtml href="#S3">3</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="S4">
               <id root="d80cc542-a0f0-4cd3-b511-e3667be9a3d9"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>4 CONTRAINDICATIONS</title>
               <text>
                  <paragraph>AIMOVIG is contraindicated in patients with serious hypersensitivity to erenumab-aooe or to any of the excipients. Reactions have included anaphylaxis and angioedema <content styleCode="italics">[see <linkHtml href="#S5.1">Warnings and Precautions (5.1)</linkHtml>]</content>.</paragraph>
               </text>
               <effectiveTime value="20250331"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>AIMOVIG is contraindicated in patients with serious hypersensitivity to erenumab-aooe or to any of the excipients. (<linkHtml href="#S4">4</linkHtml>)</paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="S5">
               <id root="67ea13d3-d2f1-4856-bc4d-40a28c317be7"/>
               <code code="43685-7" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS AND PRECAUTIONS SECTION"/>
               <title>5 WARNINGS AND PRECAUTIONS</title>
               <effectiveTime value="20250331"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="disc">
                           <item>Hypersensitivity Reactions: If a serious hypersensitivity reaction occurs, discontinue administration of AIMOVIG and initiate appropriate therapy. Hypersensitivity reactions can occur within hours to more than one week after administration. (<linkHtml href="#S5.1">5.1</linkHtml>)</item>
                           <item>Constipation with Serious Complications: Serious complications of constipation may occur. (<linkHtml href="#S5.2">5.2</linkHtml>)</item>
                           <item>Hypertension: New-onset or worsening of pre-existing hypertension may occur. (<linkHtml href="#S5.3">5.3</linkHtml>) </item>
                           <item>Raynaud's Phenomenon: New-onset or worsening of pre-existing Raynaud's phenomenon may occur. (<linkHtml href="#S5.4">5.4</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="S5.1">
                     <id root="8fa6fc65-85e2-4a0d-8b9f-80db379f8c09"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.1	Hypersensitivity Reactions</title>
                     <text>
                        <paragraph>Hypersensitivity reactions, including rash, angioedema, and anaphylaxis, have been reported with AIMOVIG in postmarketing experience. Most hypersensitivity reactions were not serious and occurred within hours of administration, although some occurred more than one week after administration. If a serious or severe hypersensitivity reaction occurs, discontinue administration of AIMOVIG and initiate appropriate therapy <content styleCode="italics">[see <linkHtml href="#S4">Contraindications (4)</linkHtml>, and <linkHtml href="#S17">Patient Counseling Information (17)</linkHtml>]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20250331"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.2">
                     <id root="3b4b9ceb-d0db-4d10-956f-93ad033ef70e"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.2	Constipation with Serious Complications</title>
                     <text>
                        <paragraph>Constipation with serious complications has been reported following the use of AIMOVIG in the postmarketing setting. There were cases that required hospitalization, including cases where surgery was necessary. In a majority of these cases, the onset of constipation was reported after the first dose of AIMOVIG; however, patients have also presented with constipation later on in treatment. AIMOVIG was discontinued in most reported cases of constipation with serious complications. Constipation was one of the most common (up to 3%) adverse reactions reported in clinical studies <content styleCode="italics">[see <linkHtml href="#S6.1">Adverse Reactions (6.1)</linkHtml>]</content>.</paragraph>
                        <paragraph>Monitor patients treated with AIMOVIG for severe constipation and manage as clinically appropriate <content styleCode="italics">[see <linkHtml href="#S17">Patient Counseling Information (17)</linkHtml>]</content>. The concurrent use of medications associated with decreased gastrointestinal motility may increase the risk for more severe constipation and the potential for constipation-related complications.</paragraph>
                     </text>
                     <effectiveTime value="20250331"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.3">
                     <id root="0242933e-7dbc-4448-a7fb-32e1fbf03a10"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.3	Hypertension</title>
                     <text>
                        <paragraph>Development of hypertension and worsening of pre-existing hypertension have been reported following the use of AIMOVIG in the postmarketing setting. Many of the patients had pre-existing hypertension or risk factors for hypertension. There were cases requiring pharmacological treatment and, in some cases, hospitalization. Hypertension may occur at any time during treatment but was most frequently reported within seven days of dose administration. In the majority of the cases, the onset or worsening of hypertension was reported after the first dose. AIMOVIG was discontinued in many of the reported cases.</paragraph>
                        <paragraph>Monitor patients treated with AIMOVIG for new-onset hypertension, or worsening of pre-existing hypertension, and consider whether discontinuation of AIMOVIG is warranted if evaluation fails to establish an alternative etiology.</paragraph>
                     </text>
                     <effectiveTime value="20250331"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.4">
                     <id root="84222066-93c4-4b11-a8ee-c1783c9f76f1"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.4	Raynaud's Phenomenon</title>
                     <text>
                        <paragraph>
                           <content styleCode="xmChange">Development of Raynaud's phenomenon and recurrence or worsening of pre-existing Raynaud's phenomenon have been reported in the postmarketing setting following the use of CGRP antagonists, including AIMOVIG. In reported cases with monoclonal antibody CGRP antagonists, symptom onset occurred a median of 71 days following dosing. Many of the cases reported serious outcomes, including hospitalizations and disability, generally related to debilitating pain. In most reported cases, discontinuation of the CGRP antagonist resulted in resolution of symptoms.</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="xmChange">AIMOVIG should be discontinued if signs or symptoms of Raynaud's phenomenon develop, and patients should be evaluated by a healthcare provider if symptoms do not resolve. Patients with a history of Raynaud's phenomenon should be monitored for, and informed about the possibility of, worsening or recurrence of signs and symptoms.</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20250331"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S6">
               <id root="bb3a28ef-609a-49fe-b619-2e9a56c52594"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>6 ADVERSE REACTIONS</title>
               <text>
                  <paragraph>The following serious adverse reactions are described below and elsewhere in the labeling:</paragraph>
                  <list listType="unordered">
                     <item>Hypersensitivity Reactions <content styleCode="italics">[see <linkHtml href="#S5.1">Warnings and Precautions (5.1)</linkHtml>]</content>
                     </item>
                     <item>Constipation with Serious Complications <content styleCode="italics">[see <linkHtml href="#S5.2">Warnings and Precautions (5.2)</linkHtml>]</content>
                     </item>
                     <item>Hypertension <content styleCode="italics">[see <linkHtml href="#S5.3">Warnings and Precautions (5.3)</linkHtml>]</content>
                     </item>
                     <item>Raynaud's Phenomenon <content styleCode="italics">[see <linkHtml href="#S5.4">Warnings and Precautions (5.4)</linkHtml>]</content>
                     </item>
                  </list>
               </text>
               <effectiveTime value="20250331"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>The most common adverse reactions in AIMOVIG clinical studies (occurring in at least 3% of treated patients and more often than placebo) are injection site reactions and constipation. (<linkHtml href="#S6.1">6.1</linkHtml>)</paragraph>
                        <br/>
                        <paragraph>
                           <content styleCode="bold">To report SUSPECTED ADVERSE REACTIONS, contact Amgen Medical Information at 1-800-77-AMGEN (1-800-772-6436) or FDA at 1-800-FDA-1088 or <content styleCode="underline">www.fda.gov/medwatch</content>.</content>
                        </paragraph>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="S6.1">
                     <id root="26b649b3-eee5-405f-9470-94715f1447cb"/>
                     <code code="90374-0" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL TRIALS EXPERIENCE SECTION"/>
                     <title>6.1	Clinical Trials Experience</title>
                     <text>
                        <paragraph>Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.</paragraph>
                        <paragraph>The safety of AIMOVIG has been evaluated in 2537 patients with migraine who received at least one dose of AIMOVIG, representing 3040.2 patient-years of exposure. Of these, 2271 patients were exposed to 70 mg or 140 mg once monthly for at least 6 months, 1305 patients were exposed for at least 12 months, and 216 patients were exposed through 5 years.</paragraph>
                        <paragraph>In placebo-controlled clinical studies (Studies 1, 2, and 3) of 2184 patients, 787 patients received at least one dose of AIMOVIG 70 mg once monthly, 507 patients received at least one dose of AIMOVIG 140 mg once monthly, and 890 patients received placebo during 3 months or 6 months of double-blind treatment <content styleCode="italics">[see <linkHtml href="#S14">Clinical Studies (14)</linkHtml>]</content>. Approximately 84% were female, 91% were white, and the mean age was 42 years at study entry.</paragraph>
                        <paragraph>The most common adverse reactions (incidence ≥ 3% and more often than placebo) in the migraine studies were injection site reactions and constipation. Table 1 summarizes the adverse reactions that occurred during the first 3 months in the migraine studies (Studies 1, 2, and 3).</paragraph>
                        <table width="75%">
                           <caption>Table 1: Adverse Reactions Occurring with an Incidence of at Least 2% for Either Dose of AIMOVIG and at Least 2% Greater than Placebo During the First 3 Months in Studies 1, 2, and 3</caption>
                           <col width="25%" align="center" valign="middle"/>
                           <col width="25%" align="center" valign="middle"/>
                           <col width="25%" align="center" valign="middle"/>
                           <col width="25%" align="center" valign="middle"/>
                           <thead>
                              <tr>
                                 <th styleCode="Lrule Rrule">Adverse Reaction</th>
                                 <th styleCode="Rrule">AIMOVIG<br/>70 mg Once Monthly<br/>N = 787<br/>%</th>
                                 <th styleCode="Rrule">AIMOVIG <br/>140 mg Once Monthly<br/>N = 507<br/>%</th>
                                 <th styleCode="Rrule">Placebo<br/>
                                    <br/>N = 890<br/>%</th>
                              </tr>
                           </thead>
                           <tbody>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">Injection site reactions<footnote>Injection site reactions include multiple adverse reactions related terms, such as injection site pain and injection site erythema.</footnote>
                                    <sup>,</sup>
                                    <footnote>The rate of injection site reactions reported in Table 1 is with the prefilled syringe. </footnote>
                                 </td>
                                 <td styleCode="Rrule">6</td>
                                 <td styleCode="Rrule">5</td>
                                 <td styleCode="Rrule">3</td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">Constipation</td>
                                 <td styleCode="Rrule">1</td>
                                 <td styleCode="Rrule">3</td>
                                 <td styleCode="Rrule">1</td>
                              </tr>
                              <tr>
                                 <td styleCode="Lrule Rrule">Cramps, muscle spasms</td>
                                 <td styleCode="Rrule">&lt; 1</td>
                                 <td styleCode="Rrule">2</td>
                                 <td styleCode="Rrule">&lt; 1</td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>In Studies 1, 2, and 3, 1.3% of patients treated with AIMOVIG 70 mg or 140 mg discontinued double-blind treatment because of adverse events. The most frequent injection site reactions were injection site pain, injection site erythema, and injection site pruritus.</paragraph>
                     </text>
                     <effectiveTime value="20250331"/>
                  </section>
               </component>
               <component>
                  <section ID="S6.2">
                     <id root="f902edf5-0d37-4723-885c-b3cafa92cc05"/>
                     <code code="90375-7" codeSystem="2.16.840.1.113883.6.1" displayName="POSTMARKETING EXPERIENCE SECTION"/>
                     <title>6.2 Postmarketing Experience</title>
                     <text>
                        <paragraph>The following adverse reactions have been identified during postapproval use of AIMOVIG. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.</paragraph>
                        <paragraph>
                           <content styleCode="italics">Immune System Disorders: </content>Hypersensitivity reactions, including rash, angioedema, and anaphylaxis <content styleCode="italics">[see <linkHtml href="#S5.1">Warnings and Precautions (5.1)</linkHtml>].</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="italics">Gastrointestinal Disorders:</content> Constipation with serious complications <content styleCode="italics">[see <linkHtml href="#S5.2">Warnings and Precautions (5.2)</linkHtml>]</content>, oral mucosal ulceration<content styleCode="italics">.</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="italics">Skin and Subcutaneous Tissue Disorders:</content> Rash, alopecia.</paragraph>
                        <paragraph>
                           <content styleCode="italics">Vascular Disorders:</content> Hypertension <content styleCode="italics">[see <linkHtml href="#S5.3">Warnings and Precautions (5.3)</linkHtml>]</content>, Raynaud's Phenomenon <content styleCode="italics">[see <linkHtml href="#S5.4">Warnings and Precautions (5.4)</linkHtml>].</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20250331"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S8">
               <id root="f3c81b67-d257-41a0-ac35-506e5c42ca00"/>
               <code code="43684-0" codeSystem="2.16.840.1.113883.6.1" displayName="USE IN SPECIFIC POPULATIONS SECTION"/>
               <title>8 USE IN SPECIFIC POPULATIONS</title>
               <effectiveTime value="20250331"/>
               <component>
                  <section ID="S8.1">
                     <id root="0f003138-0016-4a05-b361-ea5506de3518"/>
                     <code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="PREGNANCY SECTION"/>
                     <title>8.1 Pregnancy</title>
                     <effectiveTime value="20250331"/>
                     <component>
                        <section>
                           <id root="36e3ad7d-202e-489c-a16f-89ed2e340651"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Pregnancy Exposure Registry</content>
                              </paragraph>
                              <paragraph>There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to AIMOVIG during pregnancy. Patients should be encouraged to enroll by calling 1-833-244-4083 or visiting https://www.genesispregnancyregistry.com/.</paragraph>
                           </text>
                           <effectiveTime value="20250331"/>
                        </section>
                     </component>
                     <component>
                        <section>
                           <id root="8d8c97a2-a60d-43de-81c7-9d23513ee059"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Risk Summary</content>
                              </paragraph>
                              <paragraph>There are no adequate data on the developmental risk associated with the use of AIMOVIG in pregnant women. No adverse effects on offspring were observed when pregnant monkeys were administered erenumab-aooe throughout gestation <content styleCode="italics">[see <linkHtml href="#data">Data</linkHtml>].</content> Serum erenumab-aooe exposures in pregnant monkeys were greater than those in humans at clinical doses.</paragraph>
                              <paragraph>In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2%-4% and 15%-20%, respectively. The estimated rate of major birth defects (2.2%-2.9%) and miscarriage (17%) among deliveries to women with migraine are similar to rates reported in women without migraine.</paragraph>
                           </text>
                           <effectiveTime value="20250331"/>
                        </section>
                     </component>
                     <component>
                        <section ID="clinical">
                           <id root="63be6fd2-6f9f-467e-8cfe-cfa2c1480595"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Clinical Considerations</content>
                              </paragraph>
                           </text>
                           <effectiveTime value="20250331"/>
                           <component>
                              <section>
                                 <id root="2ce94102-39b8-46f4-b5fc-951e3affb377"/>
                                 <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                                 <text>
                                    <paragraph>
                                       <content styleCode="italics">Disease-Associated Maternal and/or Embryo/Fetal Risk</content>
                                    </paragraph>
                                    <paragraph>Published data have suggested that women with migraine may be at increased risk of preeclampsia and gestational hypertension during pregnancy.</paragraph>
                                 </text>
                                 <effectiveTime value="20250331"/>
                              </section>
                           </component>
                        </section>
                     </component>
                     <component>
                        <section ID="data">
                           <id root="a0162a97-f1b4-4cb6-87df-a257edae902e"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Data</content>
                              </paragraph>
                           </text>
                           <effectiveTime value="20250331"/>
                           <component>
                              <section>
                                 <id root="ae9f8047-a48f-40e3-a717-ffacfee2a7f6"/>
                                 <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                                 <text>
                                    <paragraph>
                                       <content styleCode="italics">Animal Data</content>
                                    </paragraph>
                                    <paragraph>In a study in which female monkeys were administered erenumab-aooe (0 or 50 mg/kg) twice weekly by subcutaneous injection throughout pregnancy (gestation day 20-22 to parturition), no adverse effects on offspring were observed. Serum erenumab-aooe exposures (AUC) in pregnant monkeys were approximately 20 times that in humans at a dose of 140 mg once monthly.</paragraph>
                                 </text>
                                 <effectiveTime value="20250331"/>
                              </section>
                           </component>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="S8.2">
                     <id root="83bd5f3d-8835-4222-a139-9dab634f21b9"/>
                     <code code="77290-5" codeSystem="2.16.840.1.113883.6.1" displayName="LACTATION SECTION"/>
                     <title>8.2 Lactation</title>
                     <effectiveTime value="20250331"/>
                     <component>
                        <section>
                           <id root="c04cecd0-980d-43b6-ba80-650f0e5e3edc"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Risk Summary</content>
                              </paragraph>
                              <paragraph>There are no data on the presence of erenumab-aooe in human milk, the effects on the breastfed infant, or the effects on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for AIMOVIG and any potential adverse effects on the breastfed infant from AIMOVIG or from the underlying maternal condition.</paragraph>
                           </text>
                           <effectiveTime value="20250331"/>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="S8.4">
                     <id root="90ce9787-7dab-4b10-bdf7-8c15e1058921"/>
                     <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION"/>
                     <title>8.4 Pediatric Use</title>
                     <text>
                        <paragraph>Safety and effectiveness in pediatric patients have not been established.</paragraph>
                     </text>
                     <effectiveTime value="20250331"/>
                  </section>
               </component>
               <component>
                  <section ID="S8.5">
                     <id root="5f8d2fad-eb86-4d65-a927-fc27a1f07563"/>
                     <code code="34082-8" codeSystem="2.16.840.1.113883.6.1" displayName="GERIATRIC USE SECTION"/>
                     <title>8.5 Geriatric Use</title>
                     <text>
                        <paragraph>Clinical studies of AIMOVIG did not include sufficient numbers of patients aged 65 and over to determine whether they respond differently from younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.</paragraph>
                     </text>
                     <effectiveTime value="20250331"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S11">
               <id root="2a551052-c379-45ca-b09d-fcac33abf438"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>11 DESCRIPTION</title>
               <text>
                  <paragraph>Erenumab-aooe is a human immunoglobulin G2 (IgG2) monoclonal antibody that has high affinity binding to the calcitonin gene-related peptide receptor. Erenumab-aooe is produced using recombinant DNA technology in Chinese hamster ovary (CHO) cells. It is composed of 2 heavy chains, each containing 456 amino acids, and 2 light chains of the lambda subclass, each containing 216 amino acids, with an approximate molecular weight of 150 kDa.</paragraph>
                  <paragraph>AIMOVIG (erenumab-aooe) injection is supplied as a sterile, preservative-free, clear to opalescent, colorless to light yellow solution for subcutaneous administration. Each 1 mL 70 mg single-dose prefilled autoinjector and 70 mg single-dose prefilled glass syringe contains 70 mg erenumab-aooe, acetate (1.5 mg), polysorbate 80 (0.10 mg), and sucrose (73 mg). Each 1 mL 140 mg single-dose prefilled autoinjector and 140 mg single-dose prefilled glass syringe contains 140 mg erenumab-aooe, acetate (2.0 mg), polysorbate 80 (0.10 mg), and sucrose (65 mg). Enclosed within the autoinjector is a single-dose, prefilled glass syringe. The solution of AIMOVIG has a pH of 5.2.</paragraph>
               </text>
               <effectiveTime value="20250331"/>
            </section>
         </component>
         <component>
            <section ID="S12">
               <id root="30de8f04-be62-4727-82e1-39beba53d947"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>12 CLINICAL PHARMACOLOGY</title>
               <effectiveTime value="20250331"/>
               <component>
                  <section ID="S12.1">
                     <id root="f2527432-f4f5-46a8-a1d3-f46ef3f54ca2"/>
                     <code code="43679-0" codeSystem="2.16.840.1.113883.6.1" displayName="MECHANISM OF ACTION SECTION"/>
                     <title>12.1 Mechanism of Action</title>
                     <text>
                        <paragraph>Erenumab-aooe is a human monoclonal antibody that binds to the calcitonin gene-related peptide (CGRP) receptor and antagonizes CGRP receptor function.</paragraph>
                     </text>
                     <effectiveTime value="20250331"/>
                  </section>
               </component>
               <component>
                  <section ID="S12.2">
                     <id root="40fdafe1-e650-442a-b135-53b84c4ff959"/>
                     <code code="43681-6" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACODYNAMICS SECTION"/>
                     <title>12.2 Pharmacodynamics</title>
                     <text>
                        <paragraph>In a randomized, double-blind, placebo-controlled study in healthy volunteers, concomitant administration of erenumab-aooe (140 mg intravenous, single-dose) with sumatriptan (12 mg subcutaneous, given as two 6 mg doses separated by one hour) had no effect on resting blood pressure compared with sumatriptan alone. AIMOVIG is for subcutaneous use only.</paragraph>
                     </text>
                     <effectiveTime value="20250331"/>
                  </section>
               </component>
               <component>
                  <section ID="S12.3">
                     <id root="8f48b349-17cc-4b24-ad95-5007f270377a"/>
                     <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                     <title>12.3 Pharmacokinetics</title>
                     <text>
                        <paragraph>Erenumab-aooe exhibits non-linear kinetics as a result of binding to the CGRP receptor. The C<sub>max</sub> mean and AUC<sub>last</sub> mean following subcutaneous administration of a 70 mg once monthly and a 140 mg once monthly dose in healthy volunteers or migraine patients are included in Table 2.</paragraph>
                        <paragraph>Less than 2-fold accumulation was observed in trough serum concentrations (C<sub>min</sub>) for episodic and chronic migraine patients following subcutaneous administration of 70 mg once monthly and 140 mg once monthly doses (see <linkHtml href="#table2">Table 2</linkHtml>). Serum trough concentrations approached steady state by 3 months of dosing. The effective half-life of erenumab-aooe is 28 days.</paragraph>
                        <table width="75%" ID="table2">
                           <caption>Table 2: Pharmacokinetic Parameters of AIMOVIG</caption>
                           <col width="30%" align="left" valign="bottom"/>
                           <col width="35%" align="center" valign="bottom"/>
                           <col width="35%" align="center" valign="bottom"/>
                           <thead>
                              <tr>
                                 <th styleCode="Lrule Rrule"/>
                                 <th styleCode="Rrule">AIMOVIG 70 mg<br/>Subcutaneously Once Monthly</th>
                                 <th styleCode="Rrule">AIMOVIG 140 mg<br/>Subcutaneously Once Monthly</th>
                              </tr>
                           </thead>
                           <tbody>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">C<sub>max</sub> mean (SD)<footnote ID="t2fa">SD = standard deviation </footnote>
                                    <sup>,</sup>
                                    <footnote ID="t2fb">from a single-dose study</footnote>
                                 </td>
                                 <td styleCode="Rrule">6.1 (2.1) mcg/mL</td>
                                 <td styleCode="Rrule">15.8 (4.8) mcg/mL</td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">AUC<sub>last</sub> mean (SD)<footnoteRef IDREF="t2fa"/>
                                    <sup>,</sup>
                                    <footnoteRef IDREF="t2fb"/>
                                 </td>
                                 <td styleCode="Rrule">159 (58) day*mcg/mL</td>
                                 <td styleCode="Rrule">505 (139) day*mcg/mL</td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" colspan="3">C<sub>min </sub>(SD)</td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  Episodic migraine</td>
                                 <td styleCode="Rrule">5.7 (3.1) mcg/mL</td>
                                 <td styleCode="Rrule">12.8 (6.5) mcg/mL</td>
                              </tr>
                              <tr>
                                 <td styleCode="Lrule Rrule">  Chronic migraine</td>
                                 <td styleCode="Rrule">6.2 (2.9) mcg/mL</td>
                                 <td styleCode="Rrule">14.9 (6.5) mcg/mL</td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                     <effectiveTime value="20250331"/>
                     <component>
                        <section>
                           <id root="6a45a86b-b1c6-4ee6-80d3-066e10a1a30b"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Absorption</content>
                              </paragraph>
                              <paragraph>Following a single subcutaneous dose of 70 mg or 140 mg erenumab-aooe administered to healthy adults, median peak serum concentrations were attained in approximately 6 days, and estimated absolute bioavailability was 82%.</paragraph>
                           </text>
                           <effectiveTime value="20250331"/>
                        </section>
                     </component>
                     <component>
                        <section>
                           <id root="9ccfc557-207b-469c-bb3a-0efb972e2e05"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Distribution</content>
                              </paragraph>
                              <paragraph>Following a single 140 mg intravenous dose, the mean (SD) volume of distribution during the terminal phase (V<sub>z</sub>) was estimated to be 3.86 (0.77) L.</paragraph>
                           </text>
                           <effectiveTime value="20250331"/>
                        </section>
                     </component>
                     <component>
                        <section>
                           <id root="453537ea-20bf-4e5a-8841-99dd07412aa8"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Metabolism and Excretion</content>
                              </paragraph>
                              <paragraph>Two elimination phases were observed for erenumab-aooe. At low concentrations, the elimination is predominantly through saturable binding to target (CGRP receptor), while at higher concentrations the elimination of erenumab-aooe is largely through a non-specific, non-saturable proteolytic pathway.</paragraph>
                           </text>
                           <effectiveTime value="20250331"/>
                        </section>
                     </component>
                     <component>
                        <section>
                           <id root="5e6e202c-86e4-4827-bd41-179be9e28007"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Specific Populations</content>
                              </paragraph>
                              <paragraph>The pharmacokinetics of erenumab-aooe were not affected by age, gender, race, or subtypes of migraine spectrum (episodic or chronic migraine) based on population pharmacokinetics analysis<content styleCode="italics">.</content>
                              </paragraph>
                           </text>
                           <effectiveTime value="20250331"/>
                           <component>
                              <section>
                                 <id root="21a73b18-9c1b-47c3-8400-c4ff2c5223e4"/>
                                 <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                                 <text>
                                    <paragraph>
                                       <content styleCode="italics">Patients with Renal or Hepatic Impairment</content>
                                    </paragraph>
                                    <paragraph>Population pharmacokinetic analysis of integrated data from the AIMOVIG clinical studies did not reveal a difference in the pharmacokinetics of erenumab-aooe in patients with mild or moderate renal impairment relative to those with normal renal function. Patients with severe renal impairment (eGFR &lt; 30 mL/min/1.73 m<sup>2</sup>) have not been studied. No dedicated clinical studies were conducted to evaluate the effect of hepatic impairment or renal impairment on the pharmacokinetics of erenumab-aooe. Renal or hepatic impairment is not expected to affect pharmacokinetics of erenumab-aooe.</paragraph>
                                 </text>
                                 <effectiveTime value="20250331"/>
                              </section>
                           </component>
                        </section>
                     </component>
                     <component>
                        <section>
                           <id root="5f34de45-5344-42f5-b292-473be118620a"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Drug Interaction Studies</content>
                              </paragraph>
                           </text>
                           <effectiveTime value="20250331"/>
                           <component>
                              <section>
                                 <id root="2fcad420-3097-4466-b1fe-2682a47c207a"/>
                                 <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                                 <text>
                                    <paragraph>
                                       <content styleCode="italics">P450 Enzymes</content>
                                    </paragraph>
                                    <paragraph>Erenumab-aooe is not metabolized by cytochrome P450 enzymes; therefore, interactions with concomitant medications that are substrates, inducers, or inhibitors of cytochrome P450 enzymes are unlikely.</paragraph>
                                 </text>
                                 <effectiveTime value="20250331"/>
                              </section>
                           </component>
                           <component>
                              <section>
                                 <id root="49577be6-8fba-4ac3-88b2-2d357537c8e9"/>
                                 <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                                 <text>
                                    <paragraph>
                                       <content styleCode="italics">Oral Contraceptives</content>
                                    </paragraph>
                                    <paragraph>In an open-label drug interaction study in healthy female volunteers, erenumab-aooe (140 mg subcutaneous, single-dose) did not affect the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate.</paragraph>
                                 </text>
                                 <effectiveTime value="20250331"/>
                              </section>
                           </component>
                           <component>
                              <section>
                                 <id root="7678967d-7e4a-439d-aecf-a4314b2147f2"/>
                                 <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                                 <text>
                                    <paragraph>
                                       <content styleCode="italics">Sumatriptan</content>
                                    </paragraph>
                                    <paragraph>In a study in healthy volunteers, concomitant administration of erenumab-aooe with sumatriptan had no effect on the pharmacokinetics of sumatriptan <content styleCode="italics">[see <linkHtml href="#S12.2">Clinical Pharmacology (12.2)</linkHtml>]</content>.</paragraph>
                                 </text>
                                 <effectiveTime value="20250331"/>
                              </section>
                           </component>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="S12.6">
                     <id root="209caf6e-6afc-4520-b86a-54ad8662348f"/>
                     <code code="88830-5" codeSystem="2.16.840.1.113883.6.1" displayName="IMMUNOGENICITY"/>
                     <title>12.6 	Immunogenicity</title>
                     <text>
                        <paragraph>The observed incidence of anti-drug antibodies is highly dependent on the sensitivity and specificity of the assay. Differences in assay methods preclude meaningful comparisons of the incidence of anti-drug antibodies in the studies described below with the incidence of anti-drug antibodies in other studies, including those of erenumab-aooe.</paragraph>
                        <paragraph>The immunogenicity of AIMOVIG has been evaluated using an immunoassay for the detection of binding anti-erenumab-aooe antibodies. For patients whose sera tested positive in the screening immunoassay, an <content styleCode="italics">in vitro</content> biological assay was performed to detect neutralizing antibodies.</paragraph>
                        <paragraph>In controlled studies with AIMOVIG <content styleCode="italics">[see <linkHtml href="#S14">Clinical Studies (14)</linkHtml>]</content>, the incidence of anti-erenumab-aooe antibody development was 6.2% (48/778) in patients receiving AIMOVIG 70 mg once monthly (2 of whom had <content styleCode="italics">in vitro</content> neutralizing activity) and 2.6% (13/504) in patients receiving AIMOVIG 140 mg once monthly (none of whom had <content styleCode="italics">in vitro</content> neutralizing activity). In a long-term study, including 12 weeks of double-blind treatment and up to 256 weeks of open-label treatment, the incidence of anti-erenumab-aooe antibody development was 11.1% (25/225) among patients whose AIMOVIG dose was 70 mg or 140 mg (2 of whom had <content styleCode="italics">in vitro</content> neutralizing activity). The neutralizing anti-erenumab-aooe antibody positive rate may be underestimated because of limitations of the assay. Although these data do not demonstrate an impact of anti-erenumab-aooe antibody development on the efficacy or safety of AIMOVIG in these patients, the available data are too limited to make definitive conclusions.</paragraph>
                     </text>
                     <effectiveTime value="20250331"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S13">
               <id root="eaa500c3-403e-4c9d-9759-ad94a2656211"/>
               <code code="43680-8" codeSystem="2.16.840.1.113883.6.1" displayName="NONCLINICAL TOXICOLOGY SECTION"/>
               <title>13 NONCLINICAL TOXICOLOGY</title>
               <effectiveTime value="20250331"/>
               <component>
                  <section ID="S13.1">
                     <id root="1baf8c98-3d7f-4e46-a99f-5df65129e6b6"/>
                     <code code="34083-6" codeSystem="2.16.840.1.113883.6.1" displayName="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION"/>
                     <title>13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility</title>
                     <effectiveTime value="20250331"/>
                     <component>
                        <section>
                           <id root="4ff7fd73-124e-4366-a97a-583b30d76cc3"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Carcinogenesis</content>
                              </paragraph>
                              <paragraph>The carcinogenic potential of erenumab-aooe has not been assessed.</paragraph>
                           </text>
                           <effectiveTime value="20250331"/>
                        </section>
                     </component>
                     <component>
                        <section>
                           <id root="6630800b-cfb6-41ce-9a0e-5cef970713fd"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Mutagenesis</content>
                              </paragraph>
                              <paragraph>Genetic toxicology studies of erenumab-aooe have not been conducted.</paragraph>
                           </text>
                           <effectiveTime value="20250331"/>
                        </section>
                     </component>
                     <component>
                        <section>
                           <id root="87308307-38e3-4ba4-9f79-775894d0f9c4"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Impairment of Fertility</content>
                              </paragraph>
                              <paragraph>Mating studies have not been conducted on erenumab-aooe. No histopathological changes in male or female reproductive organs were observed in monkeys administered erenumab-aooe (0, 25, or 150 mg/kg) by subcutaneous injection twice weekly for up to 6 months. Serum erenumab-aooe exposures (AUC) at the higher dose tested were more than 100 times that in humans at a dose of 140 mg once monthly.</paragraph>
                           </text>
                           <effectiveTime value="20250331"/>
                        </section>
                     </component>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S14">
               <id root="74688af8-378f-4e8b-9c51-c33e9f7c5352"/>
               <code code="34092-7" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL STUDIES SECTION"/>
               <title>14 CLINICAL STUDIES</title>
               <text>
                  <paragraph>The efficacy of AIMOVIG was evaluated as a preventive treatment of episodic or chronic migraine in three randomized, double-blind, placebo-controlled studies: two studies in patients with episodic migraine (4 to 14 migraine days per month) (Study 1 and Study 2) and one study in patients with chronic migraine (≥ 15 headache days per month with ≥ 8 migraine days per month) (Study 3). The studies enrolled patients with a history of migraine, with or without aura, according to the International Classification of Headache Disorders (ICHD-III) diagnostic criteria.</paragraph>
               </text>
               <effectiveTime value="20250331"/>
               <component>
                  <section>
                     <id root="b75376c6-c98c-49fa-a9fe-71d6fc4d6232"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Episodic Migraine</content>
                        </paragraph>
                        <paragraph>Study 1 (NCT 02456740) was a randomized, multi-center, 6-month, placebo-controlled, double-blind study evaluating AIMOVIG for the preventive treatment of episodic migraine. A total of 955 patients with a history of episodic migraine were randomized to receive either AIMOVIG 70 mg (N = 317), AIMOVIG 140 mg (N = 319), or placebo (N = 319) by subcutaneous injection once monthly (QM) for 6 months. Patients were allowed to use acute headache treatments including migraine-specific medications (i.e., triptans, ergotamine derivatives) and NSAIDs during the study.</paragraph>
                        <paragraph>The study excluded patients with medication overuse headache as well as patients with myocardial infarction, stroke, transient ischemic attacks, unstable angina, coronary artery bypass surgery, or other revascularization procedures within 12 months prior to screening.</paragraph>
                        <paragraph>The primary efficacy endpoint was the change from baseline in mean monthly migraine days over months 4 to 6. Secondary endpoints included the achievement of a ≥ 50% reduction from baseline in mean monthly migraine days over months 4 to 6 ("≥ 50% MMD responders"), the change from baseline in mean monthly acute migraine-specific medication days over months 4 to 6, and the change from baseline in mean Migraine Physical Function Impact Diary (MPFID) over months 4 to 6. The MPFID measures the impact of migraine on everyday activities (EA) and physical impairment (PI) using an electronic diary administered daily. Monthly MPFID scores are averaged over 28 days, including days with and without migraine; scores are scaled from 0 to 100. Higher scores indicate worse impact on EA and PI. Reductions from baseline in MPFID scores indicate improvement.</paragraph>
                        <paragraph>A total of 858 (90%) patients completed the 6-month double-blind study. Patients had a median age of 42 years (range: 18 to 65 years), 85% were female, and 89% were white. Three percent of patients were taking concomitant preventive treatments for migraine. The mean migraine frequency at baseline was approximately 8 migraine days per month and was similar across treatment groups.</paragraph>
                        <paragraph>AIMOVIG treatment demonstrated statistically significant improvements for key efficacy endpoints compared to placebo, as summarized in Table 3.</paragraph>
                        <table width="75%">
                           <caption>Table 3: Efficacy Endpoints Over Months 4 to 6 in Study 1</caption>
                           <col width="30%" align="left" valign="top"/>
                           <col width="20%" align="center" valign="top"/>
                           <col width="30%" align="center" valign="top"/>
                           <col width="20%" align="center" valign="top"/>
                           <thead>
                              <tr>
                                 <th styleCode="Lrule Rrule"/>
                                 <th styleCode="Rrule">AIMOVIG<br/>70 mg Once  Monthly</th>
                                 <th styleCode="Rrule">AIMOVIG<br/>140 mg  Once Monthly</th>
                                 <th styleCode="Rrule">Placebo</th>
                              </tr>
                              <tr>
                                 <th styleCode="Lrule Rrule"/>
                                 <th styleCode="Rrule" valign="bottom">N = 312</th>
                                 <th styleCode="Rrule" valign="bottom">N = 318</th>
                                 <th styleCode="Rrule" valign="bottom">N = 316</th>
                              </tr>
                           </thead>
                           <tbody>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" colspan="4">
                                    <content styleCode="bold">Monthly Migraine Days (MMD)</content>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  Change from baseline</td>
                                 <td styleCode="Rrule">−3.2</td>
                                 <td styleCode="Rrule">−3.7</td>
                                 <td styleCode="Rrule">−1.8</td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  Difference from placebo</td>
                                 <td styleCode="Rrule">−1.4</td>
                                 <td styleCode="Rrule">−1.9</td>
                                 <td styleCode="Rrule"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  <content styleCode="italics">p-</content>value</td>
                                 <td styleCode="Rrule">&lt; 0.001</td>
                                 <td styleCode="Rrule">&lt; 0.001</td>
                                 <td styleCode="Rrule"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" colspan="4">
                                    <content styleCode="bold">≥ 50% MMD responders</content>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  % Responders</td>
                                 <td styleCode="Rrule">43.3%</td>
                                 <td styleCode="Rrule">50.0%</td>
                                 <td styleCode="Rrule">26.6%</td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  Difference from placebo</td>
                                 <td styleCode="Rrule">16.7%</td>
                                 <td styleCode="Rrule">23.4%</td>
                                 <td styleCode="Rrule"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  Odds ratio relative to placebo</td>
                                 <td styleCode="Rrule">2.1</td>
                                 <td styleCode="Rrule">2.8</td>
                                 <td styleCode="Rrule"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  <content styleCode="italics">p-</content>value</td>
                                 <td styleCode="Rrule">&lt; 0.001</td>
                                 <td styleCode="Rrule">&lt; 0.001</td>
                                 <td styleCode="Rrule"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" colspan="4">
                                    <content styleCode="bold">Monthly acute migraine-specific medication days</content>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  Change from baseline</td>
                                 <td styleCode="Rrule">−1.1</td>
                                 <td styleCode="Rrule">−1.6</td>
                                 <td styleCode="Rrule">−0.2</td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  Difference from placebo</td>
                                 <td styleCode="Rrule">−0.9</td>
                                 <td styleCode="Rrule">−1.4</td>
                                 <td styleCode="Rrule"/>
                              </tr>
                              <tr>
                                 <td styleCode="Lrule Rrule">  <content styleCode="italics">p-</content>value</td>
                                 <td styleCode="Rrule">&lt; 0.001</td>
                                 <td styleCode="Rrule">&lt; 0.001</td>
                                 <td styleCode="Rrule"/>
                              </tr>
                           </tbody>
                        </table>
                        <table width="100%" styleCode="Noautorules">
                           <caption>Figure 1: Change from Baseline in Monthly Migraine Days in Study 1<footnote>Least-square means and 95% confidence intervals are presented.</footnote>
                           </caption>
                           <col width="100%" align="left" valign="top"/>
                           <tbody>
                              <tr>
                                 <td>
                                    <paragraph>
                                       <renderMultiMedia referencedObject="MM1"/>
                                    </paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>Figure 2 shows the distribution of change from baseline in mean monthly migraine days over months 4 to 6 in bins of 2 days by treatment group. A treatment benefit over placebo for both doses of AIMOVIG is seen across a range of changes from baseline in monthly migraine days.</paragraph>
                        <table width="100%" styleCode="Noautorules">
                           <caption>Figure 2: Distribution of Change from Baseline in Mean Monthly Migraine Days Over Months 4 to 6 by Treatment Group in Study 1</caption>
                           <col width="100%" align="left" valign="top"/>
                           <tfoot>
                              <tr>
                                 <td align="left" valign="top">Figure excludes patients with missing data.</td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr>
                                 <td>
                                    <paragraph>
                                       <renderMultiMedia referencedObject="MM2"/>
                                    </paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>Compared to placebo, patients treated with AIMOVIG 70 mg once monthly and 140 mg once monthly showed greater reductions from baseline in mean monthly MPFID everyday activity scores averaged over months 4 to 6 [difference from placebo: −2.2 for AIMOVIG 70 mg and −2.6 for AIMOVIG 140 mg; <content styleCode="italics">p-</content>value &lt; 0.001 for both], and in mean monthly MPFID physical impairment scores averaged over months 4 to 6 [difference from placebo: −1.9 for AIMOVIG 70 mg and −2.4 for AIMOVIG 140 mg; <content styleCode="italics">p-</content>value &lt; 0.001 for both].</paragraph>
                        <paragraph>Study 2 (NCT 02483585) was a randomized, multi-center, 3-month, placebo-controlled, double-blind study evaluating AIMOVIG for the preventive treatment of episodic migraine. A total of 577 patients with a history of episodic migraine were randomized to receive either AIMOVIG 70 mg (N = 286) or placebo (N = 291) by subcutaneous injection once monthly for 3 months. Patients were allowed to use acute headache treatments including migraine-specific medications (i.e., triptans, ergotamine derivatives) and NSAIDs during the study.</paragraph>
                        <paragraph>The study excluded patients with medication overuse headache as well as patients with myocardial infarction, stroke, transient ischemic attacks, unstable angina, coronary artery bypass surgery, or other revascularization procedures within 12 months prior to screening.</paragraph>
                        <paragraph>The primary efficacy endpoint was the change from baseline in monthly migraine days at month 3. Secondary endpoints included the achievement of a ≥ 50% reduction from baseline in monthly migraine days ("≥ 50% MMD responders"), the change from baseline in monthly acute migraine-specific medication days at month 3, and the proportion of patients with at least a 5-point score reduction from baseline in MPFID at month 3.</paragraph>
                        <paragraph>A total of 546 (95%) patients completed the 3-month double-blind study. Patients had a median age of 43 years (range: 18 to 65 years), 85% were female, and 90% were white. Six to seven percent of patients were taking concomitant preventive migraine treatment. The mean migraine frequency at baseline was approximately 8 migraine days per month and was similar between treatment groups.</paragraph>
                        <paragraph>AIMOVIG treatment demonstrated statistically significant improvements for key efficacy endpoints compared to placebo, as summarized in Table 4.</paragraph>
                        <table width="75%">
                           <caption>Table 4: Efficacy Endpoints at Month 3 for Study 2</caption>
                           <col width="40%" align="left" valign="top"/>
                           <col width="30%" align="center" valign="top"/>
                           <col width="30%" align="center" valign="top"/>
                           <thead>
                              <tr>
                                 <th styleCode="Lrule Rrule"/>
                                 <th styleCode="Rrule">AIMOVIG<br/>70 mg Once Monthly</th>
                                 <th styleCode="Rrule">Placebo</th>
                              </tr>
                              <tr>
                                 <th styleCode="Lrule Rrule"/>
                                 <th styleCode="Rrule" valign="bottom">N = 282</th>
                                 <th styleCode="Rrule" valign="bottom">N = 288</th>
                              </tr>
                           </thead>
                           <tbody>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" colspan="3">
                                    <content styleCode="bold">Monthly Migraine Days (MMD)</content>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  Change from baseline</td>
                                 <td styleCode="Rrule">−2.9</td>
                                 <td styleCode="Rrule">−1.8</td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  Difference from placebo</td>
                                 <td styleCode="Rrule">−1.0</td>
                                 <td styleCode="Rrule"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  <content styleCode="italics">p-</content>value</td>
                                 <td styleCode="Rrule">&lt; 0.001</td>
                                 <td styleCode="Rrule"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" colspan="3">
                                    <content styleCode="bold">≥ 50% MMD responders</content>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  % Responders</td>
                                 <td styleCode="Rrule">39.7%</td>
                                 <td styleCode="Rrule">29.5%</td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  Difference from placebo</td>
                                 <td styleCode="Rrule">10.2%</td>
                                 <td styleCode="Rrule"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  Odds ratio relative to placebo</td>
                                 <td styleCode="Rrule">1.6</td>
                                 <td styleCode="Rrule"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  <content styleCode="italics">p-</content>value</td>
                                 <td styleCode="Rrule">0.010</td>
                                 <td styleCode="Rrule"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" colspan="3">
                                    <content styleCode="bold">Monthly acute migraine-specific medication days</content>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  Change from baseline</td>
                                 <td styleCode="Rrule">−1.2</td>
                                 <td styleCode="Rrule">−0.6</td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  Difference from placebo</td>
                                 <td styleCode="Rrule">−0.6</td>
                                 <td styleCode="Rrule"/>
                              </tr>
                              <tr>
                                 <td styleCode="Lrule Rrule">  <content styleCode="italics">p-</content>value</td>
                                 <td styleCode="Rrule">0.002</td>
                                 <td styleCode="Rrule"/>
                              </tr>
                           </tbody>
                        </table>
                        <table width="100%" styleCode="Noautorules">
                           <caption>Figure 3: Change from Baseline in Monthly Migraine Days in Study 2<footnote>Least-square means and 95% confidence intervals are presented.</footnote>
                           </caption>
                           <col width="100%" align="left" valign="top"/>
                           <tbody>
                              <tr>
                                 <td>
                                    <paragraph>
                                       <renderMultiMedia referencedObject="MM3"/>
                                    </paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>Figure 4 shows the distribution of change from baseline in monthly migraine days at month 3 in bins of 2 days by treatment group. A treatment benefit over placebo for AIMOVIG is seen across a range of changes from baseline in monthly migraine days.</paragraph>
                        <table width="100%" styleCode="Noautorules">
                           <caption>Figure 4: Distribution of Change from Baseline in Monthly Migraine Days at Month 3 by Treatment Group in Study 2</caption>
                           <col width="100%" align="left" valign="top"/>
                           <tfoot>
                              <tr>
                                 <td align="left" valign="top">Figure excludes patients with missing data.</td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr>
                                 <td>
                                    <paragraph>
                                       <renderMultiMedia referencedObject="MM4"/>
                                    </paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>The pre-specified analysis for the MPFID was based on at least a 5-point reduction within-patient responder definition. AIMOVIG 70 mg once monthly was not significantly better than placebo for the proportion of responders for everyday activity [difference from placebo: 4.7%; odds ratio = 1.2; <content styleCode="italics">p-</content>value = 0.26] and physical impairment [difference from placebo: 5.9%; odds ratio = 1.3; <content styleCode="italics">p-</content>value = 0.13]. In an exploratory analysis of the change from baseline in the mean MPFID scores at month 3, patients treated with AIMOVIG 70 mg, as compared to placebo, showed nominally greater reductions of physical impairment scores [difference from placebo: -1.3; <content styleCode="italics">p-</content>value = 0.021], but not of everyday activities scores [difference from placebo: -1.1; <content styleCode="italics">p-</content>value = 0.061].</paragraph>
                     </text>
                     <effectiveTime value="20250331"/>
                     <component>
                        <observationMedia ID="MM1">
                           <text>Figure 1</text>
                           <value xsi:type="ED" mediaType="image/jpeg">
                              <reference value="aimovig-01.jpg"/>
                           </value>
                        </observationMedia>
                     </component>
                     <component>
                        <observationMedia ID="MM2">
                           <text>Figure 2</text>
                           <value xsi:type="ED" mediaType="image/jpeg">
                              <reference value="aimovig-02.jpg"/>
                           </value>
                        </observationMedia>
                     </component>
                     <component>
                        <observationMedia ID="MM3">
                           <text>Figure 3</text>
                           <value xsi:type="ED" mediaType="image/jpeg">
                              <reference value="aimovig-03.jpg"/>
                           </value>
                        </observationMedia>
                     </component>
                     <component>
                        <observationMedia ID="MM4">
                           <text>Figure 4</text>
                           <value xsi:type="ED" mediaType="image/jpeg">
                              <reference value="aimovig-04.jpg"/>
                           </value>
                        </observationMedia>
                     </component>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="21c51332-9185-40c0-ab24-c34866d554f3"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Chronic Migraine</content>
                        </paragraph>
                        <paragraph>Study 3 (NCT 02066415) was a randomized, multi-center, 3-month, placebo-controlled, double-blind study evaluating AIMOVIG as a preventive treatment of chronic migraine. A total of 667 patients with a history of chronic migraine with or without aura were randomized to receive AIMOVIG 70 mg (N = 191), AIMOVIG 140 mg (N = 190), or placebo (N = 286) by subcutaneous injections once monthly for 3 months. Patients were allowed to use acute headache treatments including migraine-specific medications (i.e., triptans, ergotamine derivatives) and NSAIDs during the study.</paragraph>
                        <paragraph>The study excluded patients with medication overuse headache caused by opiate overuse and patients with concurrent use of migraine preventive treatments. Patients with myocardial infarction, stroke, transient ischemic attacks, unstable angina, coronary artery bypass surgery, or other revascularization procedures within 12 months prior to screening were also excluded.</paragraph>
                        <paragraph>The primary efficacy endpoint was the change from baseline in monthly migraine days at month 3. Secondary endpoints included the achievement of a ≥ 50% reduction from baseline in monthly migraine days ("≥ 50% MMD responders") and change from baseline in monthly acute migraine-specific medication days at month 3.</paragraph>
                        <paragraph>A total of 631 (95%) patients completed the 3-month double-blind study. Patients had a median age of 43 years (range: 18 to 66 years), 83% were female, and 94% were white. The mean migraine frequency at baseline was approximately 18 migraine days per month and was similar across treatment groups.</paragraph>
                        <paragraph>AIMOVIG treatment demonstrated statistically significant improvements for key efficacy outcomes compared to placebo, as summarized in Table 5.</paragraph>
                        <table width="75%">
                           <caption>Table 5: Efficacy Endpoints at Month 3 in Study 3</caption>
                           <col width="25%" align="left" valign="top"/>
                           <col width="25%" align="center" valign="top"/>
                           <col width="25%" align="center" valign="top"/>
                           <col width="25%" align="center" valign="top"/>
                           <thead>
                              <tr>
                                 <th styleCode="Lrule Rrule"/>
                                 <th styleCode="Rrule">AIMOVIG<br/>70 mg Once Monthly</th>
                                 <th styleCode="Rrule">AIMOVIG<br/>140 mg Once Monthly</th>
                                 <th styleCode="Rrule">Placebo</th>
                              </tr>
                              <tr>
                                 <th styleCode="Lrule Rrule"/>
                                 <th styleCode="Rrule" valign="bottom">N = 188</th>
                                 <th styleCode="Rrule" valign="bottom">N = 187</th>
                                 <th styleCode="Rrule" valign="bottom">N = 281</th>
                              </tr>
                           </thead>
                           <tbody>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" colspan="4">
                                    <content styleCode="bold">Monthly Migraine Days (MMD)</content>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  Change from baseline</td>
                                 <td styleCode="Rrule">−6.6</td>
                                 <td styleCode="Rrule">−6.6</td>
                                 <td styleCode="Rrule">−4.2</td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  Difference from placebo</td>
                                 <td styleCode="Rrule">−2.5</td>
                                 <td styleCode="Rrule">−2.5</td>
                                 <td styleCode="Rrule"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  <content styleCode="italics">p-</content>value</td>
                                 <td styleCode="Rrule">&lt; 0.001</td>
                                 <td styleCode="Rrule">&lt; 0.001</td>
                                 <td styleCode="Rrule"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" colspan="4">
                                    <content styleCode="bold">≥ 50% MMD responders</content>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  % Responders</td>
                                 <td styleCode="Rrule">39.9%</td>
                                 <td styleCode="Rrule">41.2%</td>
                                 <td styleCode="Rrule">23.5%</td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  Difference from placebo</td>
                                 <td styleCode="Rrule">16.4%</td>
                                 <td styleCode="Rrule">17.7%</td>
                                 <td styleCode="Rrule"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  Odds ratio relative to placebo</td>
                                 <td styleCode="Rrule">2.2</td>
                                 <td styleCode="Rrule">2.3</td>
                                 <td styleCode="Rrule"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  <content styleCode="italics">p-</content>value</td>
                                 <td styleCode="Rrule">&lt; 0.001</td>
                                 <td styleCode="Rrule">&lt; 0.001</td>
                                 <td styleCode="Rrule"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" colspan="4">
                                    <content styleCode="bold">Monthly acute migraine-specific medication days</content>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  Change from baseline</td>
                                 <td styleCode="Rrule">−3.5</td>
                                 <td styleCode="Rrule">−4.1</td>
                                 <td styleCode="Rrule">−1.6</td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule">  Difference from placebo</td>
                                 <td styleCode="Rrule">−1.9</td>
                                 <td styleCode="Rrule">−2.6</td>
                                 <td styleCode="Rrule"/>
                              </tr>
                              <tr>
                                 <td styleCode="Lrule Rrule">  <content styleCode="italics">p-</content>value</td>
                                 <td styleCode="Rrule">&lt; 0.001</td>
                                 <td styleCode="Rrule">&lt; 0.001</td>
                                 <td styleCode="Rrule"/>
                              </tr>
                           </tbody>
                        </table>
                        <table width="100%" styleCode="Noautorules">
                           <caption>Figure 5: Change from Baseline in Monthly Migraine Days in Study 3<footnote>Least-square means and 95% confidence intervals are presented.</footnote>
                           </caption>
                           <col width="100%" align="left" valign="top"/>
                           <tbody>
                              <tr>
                                 <td>
                                    <paragraph>
                                       <renderMultiMedia referencedObject="MM5"/>
                                    </paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>Figure 6 shows the distribution of change from baseline in monthly migraine days at month 3 in bins of 3 days by treatment group. A treatment benefit over placebo for both doses of AIMOVIG is seen across a range of changes from baseline in migraine days.</paragraph>
                        <table width="100%" styleCode="Noautorules">
                           <caption>Figure 6: Distribution of Change from Baseline in Monthly Migraine Days at Month 3 by Treatment Group in Study 3</caption>
                           <col width="100%" align="left" valign="top"/>
                           <tfoot>
                              <tr>
                                 <td align="left" valign="top">Figure excludes patients with missing data.</td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr>
                                 <td>
                                    <paragraph>
                                       <renderMultiMedia referencedObject="MM6"/>
                                    </paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                     <effectiveTime value="20250331"/>
                     <component>
                        <observationMedia ID="MM5">
                           <text>Figure 5</text>
                           <value xsi:type="ED" mediaType="image/jpeg">
                              <reference value="aimovig-05.jpg"/>
                           </value>
                        </observationMedia>
                     </component>
                     <component>
                        <observationMedia ID="MM6">
                           <text>Figure 6</text>
                           <value xsi:type="ED" mediaType="image/jpeg">
                              <reference value="aimovig-06.jpg"/>
                           </value>
                        </observationMedia>
                     </component>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S16">
               <id root="d3cc4782-fbdb-435f-8187-d97b4f339c2a"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>16 HOW SUPPLIED/STORAGE AND HANDLING</title>
               <effectiveTime value="20250331"/>
               <component>
                  <section ID="S16.1">
                     <id root="6cc8e50b-def3-4f55-b2f3-d804227a1114"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>16.1	How Supplied</title>
                     <text>
                        <paragraph>AIMOVIG (erenumab-aooe) injection is a sterile, clear to opalescent, colorless to light yellow solution for subcutaneous administration.</paragraph>
                        <paragraph>AIMOVIG prefilled autoinjectors and prefilled syringes are not made with natural rubber latex. Each single-dose prefilled SureClick<sup>®</sup> autoinjector or single-dose prefilled syringe of AIMOVIG contains a Type 1 glass syringe and stainless steel needle and delivers 1 mL of 70 mg/mL or 140 mg/mL solution.</paragraph>
                        <paragraph>AIMOVIG is supplied as follows:</paragraph>
                        <paragraph>
                           <content styleCode="underline">SureClick<sup>®</sup> Autoinjector</content>
                        </paragraph>
                        <list>
                           <item>Pack of 1 autoinjector: 70 mg/mL single-dose prefilled autoinjector<br/>      NDC 55513-841-01</item>
                           <item>Pack of 1 autoinjector: 140 mg/mL single-dose prefilled autoinjector<br/>      NDC 55513-843-01</item>
                        </list>
                        <paragraph>
                           <content styleCode="underline">Syringe</content>
                        </paragraph>
                        <list>
                           <item>Pack of 1 syringe: 70 mg/mL single-dose prefilled syringe<br/>      NDC 55513-840-01</item>
                           <item>Pack of 1 syringe: 140 mg/mL single-dose prefilled syringe<br/>      NDC 55513-842-01</item>
                        </list>
                     </text>
                     <effectiveTime value="20250331"/>
                  </section>
               </component>
               <component>
                  <section ID="S16.2">
                     <id root="ffe07d71-265e-4530-b827-de0a29e6f65e"/>
                     <code code="44425-7" codeSystem="2.16.840.1.113883.6.1" displayName="STORAGE AND HANDLING SECTION"/>
                     <title>16.2	Storage and Handling</title>
                     <text>
                        <list listType="unordered">
                           <item> Store refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light until time of use.</item>
                           <item> If removed from the refrigerator, AIMOVIG should be kept at room temperature (up to 25°C [77°F]) in the original carton and must be used within 7 days. Throw away AIMOVIG that has been left at room temperature for more than 7 days.</item>
                           <item> Do not freeze.</item>
                           <item> Do not shake.</item>
                        </list>
                     </text>
                     <effectiveTime value="20250331"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S17">
               <id root="7798cb14-9380-4580-b1ed-b9c210d1b74a"/>
               <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
               <title>17 PATIENT COUNSELING INFORMATION</title>
               <text>
                  <paragraph>Advise the patient to read the FDA-approved patient labeling (Patient Information and Instructions for Use).</paragraph>
               </text>
               <effectiveTime value="20250331"/>
               <component>
                  <section>
                     <id root="7b53cfa9-f81f-4ce2-bd3e-2d721c4003a5"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Information on Preparation and Administration</content>
                        </paragraph>
                        <paragraph>Provide guidance to patients and caregivers on proper subcutaneous administration technique, including aseptic technique, and how to use the single-dose prefilled autoinjector or single-dose prefilled syringe <content styleCode="italics">[see <linkHtml href="#S2.2">Dosage and Administration (2.2)</linkHtml>]</content>. Instruct patients and/or caregivers to read and follow the Instructions for Use each time they use AIMOVIG.</paragraph>
                        <paragraph>Advise patients to let AIMOVIG sit at room temperature for at least 30 minutes prior to administration <content styleCode="italics">[see <linkHtml href="#S2.2">Dosage and Administration (2.2)</linkHtml>]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20250331"/>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="0ec73c0e-72ac-493e-9584-3933c570f616"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Hypersensitivity Reactions</content>
                        </paragraph>
                        <paragraph>Advise patients to seek immediate medical attention if they experience any symptoms of serious or severe hypersensitivity reactions <content styleCode="italics">[see <linkHtml href="#S5.1">Warnings and Precautions (5.1)</linkHtml>]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20250331"/>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="6cb11594-1eba-4c8b-9945-e6bdb04c36db"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Constipation with Serious Complications</content>
                        </paragraph>
                        <paragraph>Advise patients that constipation with serious complications can occur with AIMOVIG and that they should contact their healthcare providers if they experience severe constipation <content styleCode="italics">[see <linkHtml href="#S5.2">Warnings and Precautions (5.2)</linkHtml>]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20250331"/>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="4b0e306d-9cdf-43ae-9bd5-91bd1e564e11"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Hypertension</content>
                        </paragraph>
                        <paragraph>Advise patients that development of hypertension and worsening of pre-existing hypertension can occur with AIMOVIG and that they should contact their healthcare providers if they experience elevation in their blood pressure <content styleCode="italics">[see <linkHtml href="#S5.3">Warnings and Precautions (5.3)</linkHtml>]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20250331"/>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="26174c1a-11bd-48e8-b1db-6cd9d999a325"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <text>
                        <paragraph>Pregnancy</paragraph>
                        <paragraph>Advise patients that there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to AIMOVIG during pregnancy <content styleCode="italics">[see <linkHtml href="#S8.1">Use in Specific Populations (8.1)</linkHtml>].</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20250331"/>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="2d2d856b-1042-4034-b8bd-5a9f8e42e278"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Raynaud's Phenomenon</content>
                        </paragraph>
                        <paragraph>Inform patients that Raynaud's phenomenon can develop or worsen with AIMOVIG. Advise patients to discontinue AIMOVIG and contact their healthcare provider if they experience signs or symptoms of Raynaud's phenomenon <content styleCode="italics">[see <linkHtml href="#S5.4">Warnings and Precautions (5.4)</linkHtml>]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20250331"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="75363116-30cd-43c3-b185-b5e673122cd8"/>
               <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
               <text>
                  <paragraph>For more information, go to www.aimovig.com or call 1-800-77-AMGEN (1-800-772-6436).</paragraph>
                  <paragraph>AIMOVIG<sup>®</sup> (erenumab-aooe)</paragraph>
                  <paragraph>
                     <content styleCode="bold">Manufactured by:</content>
                     <br/>Amgen Inc.<br/>One Amgen Center Drive<br/>Thousand Oaks, CA 91320-1799 U.S.A.<br/>U.S. License No. 1080</paragraph>
                  <paragraph>Patent: http://pat.amgen.com/aimovig/ <br/>© 2018-2025 Amgen Inc. All rights reserved. <br/>[part number] V12</paragraph>
               </text>
               <effectiveTime value="20250331"/>
            </section>
         </component>
         <component>
            <section>
               <id root="42594389-bddf-4310-b17c-fa36798bc55a"/>
               <code code="42230-3" codeSystem="2.16.840.1.113883.6.1" displayName="SPL PATIENT PACKAGE INSERT SECTION"/>
               <text>
                  <table width="100%">
                     <col width="85%" align="left" valign="top"/>
                     <col width="15%" align="left" valign="top"/>
                     <thead>
                        <tr>
                           <th styleCode="Lrule Rrule" align="center" colspan="2">Patient Information <br/>AIMOVIG<sup>®</sup> (AIM-oh-vig) (erenumab-aooe) <br/>injection, for subcutaneous use</th>
                        </tr>
                     </thead>
                     <tfoot>
                        <tr>
                           <td align="left" valign="top">This Patient Information has been approved by the U.S. Food and Drug Administration.<br/>[part number] v10</td>
                           <td align="right" valign="top">Revised: 3/2025    </td>
                        </tr>
                     </tfoot>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td styleCode="Lrule Rrule" colspan="2">
                              <content styleCode="bold">What is AIMOVIG?</content>
                              <br/>AIMOVIG is a prescription medicine used for the preventive treatment of migraine in adults. <br/>It is not known if AIMOVIG is safe and effective in children under 18 years of age.</td>
                        </tr>
                        <tr styleCode="Botrule">
                           <td styleCode="Lrule Rrule" colspan="2">
                              <content styleCode="bold">Who should not use AIMOVIG?</content>
                              <br/>
                              <content styleCode="bold">Do not</content> use AIMOVIG if you are allergic to erenumab-aooe or any of the ingredients in AIMOVIG. See the end of this Patient Information for a complete list of ingredients in AIMOVIG.</td>
                        </tr>
                        <tr styleCode="Botrule">
                           <td styleCode="Lrule Rrule" colspan="2">Before you start using AIMOVIG, tell your healthcare provider about all your medical conditions, including if you: 									<list listType="unordered" styleCode="disc">
                                 <item>have high blood pressure</item>
                                 <item>have circulation problems in your fingers and toes</item>
                                 <item>
                                    <content styleCode="bold">are pregnant or plan to become pregnant.</content> It is not known if AIMOVIG will harm your unborn baby.<list listType="unordered" styleCode="circle">
                                       <item>Pregnancy Registry: There is a pregnancy registry for women who take AIMOVIG. The purpose of this registry is to collect information about your health and your baby's health. You may enroll yourself by calling 1-833-244-4083 or visiting https://www.genesispregnancyregistry.com/. Or you may talk to your healthcare provider about how you can take part in this registry.</item>
                                    </list>
                                 </item>
                                 <item>
                                    <content styleCode="bold">are breastfeeding or plan to breastfeed.</content> It is not known if AIMOVIG passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby while using AIMOVIG.</item>
                              </list>Tell your pharmacist or healthcare provider about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.</td>
                        </tr>
                        <tr styleCode="Botrule">
                           <td styleCode="Lrule Rrule" colspan="2">
                              <content styleCode="bold">How should I take AIMOVIG?</content>
                              <list>
                                 <item>
                                    <content styleCode="bold">See the detailed "Instructions for Use" on complete information on how to take AIMOVIG.</content>
                                 </item>
                                 <item>Take AIMOVIG exactly as your healthcare provider tells you to take it. </item>
                                 <item>Before you inject, always check the label of your single-dose prefilled autoinjector or single-dose prefilled syringe to make sure you have the correct medicine and the correct dose of AIMOVIG.</item>
                                 <item>Also, before you inject, leave AIMOVIG at room temperature for at least 30 minutes protected from direct sunlight.</item>
                                 <item>AIMOVIG is injected under your skin (subcutaneously) 1 time each month.</item>
                                 <item>AIMOVIG comes in 2 different types of devices: a single-dose (1 time) prefilled autoinjector or a single-dose (1 time) prefilled syringe. Your healthcare provider will prescribe the type and dose that is best for you.</item>
                                 <item>If you forget to take AIMOVIG or are not able to take the dose at the regular time, take your missed dose as soon as you remember. After that, you can continue to take AIMOVIG 1 time each month from the date of your last dose.</item>
                              </list>
                           </td>
                        </tr>
                        <tr styleCode="Botrule">
                           <td styleCode="Lrule Rrule" colspan="2">
                              <content styleCode="bold">What are possible side effects of AIMOVIG?<br/>AIMOVIG may cause serious side effects, including:</content>
                              <list>
                                 <item>
                                    <content styleCode="bold">Allergic reactions.</content> Allergic reactions, including rash or swelling can happen after receiving AIMOVIG. This can happen within hours to days after using AIMOVIG. Call your healthcare provider or get emergency medical help right away if you have any of the following symptoms of an allergic reaction: <list listType="unordered" styleCode="circle">
                                       <item>swelling of the face, mouth, tongue, or throat</item>
                                       <item>trouble breathing</item>
                                    </list>
                                 </item>
                                 <item>
                                    <content styleCode="bold">Constipation with serious complications.</content> Severe constipation can happen after receiving AIMOVIG. In some cases, people have been hospitalized or needed surgery. Contact your healthcare provider if you have severe constipation or constipation associated with symptoms such as severe or constant belly pain, vomiting, swelling of belly or bloating.</item>
                                 <item>
                                    <content styleCode="bold">High blood pressure.</content> High blood pressure or worsening of high blood pressure can happen after receiving AIMOVIG. Contact your healthcare provider if you have an increase in blood pressure.</item>
                                 <item>
                                    <content styleCode="bold">Raynaud's phenomenon.</content> A type of circulation problem can worsen or happen after receiving AIMOVIG. Raynaud's phenomenon can lead to your fingers or toes feeling numb, cool, or painful, or changing color from pale, to blue, to red. Contact your healthcare provider if these symptoms occur.</item>
                              </list>The most common side effects of AIMOVIG include: pain, redness, or swelling at the injection site and constipation.<br/>Tell your healthcare provider if you have any side effect that bothers you or that does not go away.<br/>These are not all of the possible side effects of AIMOVIG. Ask your pharmacist or healthcare provider for more information.<br/>Call your healthcare provider for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to Amgen at 1-800-77-AMGEN (1-800-772-6436).</td>
                        </tr>
                        <tr styleCode="Botrule">
                           <td styleCode="Lrule Rrule" colspan="2">
                              <content styleCode="bold">How should I store AIMOVIG?</content>
                              <list>
                                 <item>Store AIMOVIG in the refrigerator between 36°F to 46°F (2°C to 8°C). </item>
                                 <item>Keep AIMOVIG in the original carton. This will protect the medicine from light. </item>
                                 <item>After removing AIMOVIG from the refrigerator, it can be stored at room temperature between 68°F to 77°F (20°C to 25°C) for up to 7 days.</item>
                                 <item>Throw away AIMOVIG that has been left at room temperature for more than 7 days. </item>
                                 <item>
                                    <content styleCode="bold">Do not</content> freeze. </item>
                                 <item>
                                    <content styleCode="bold">Do not</content> shake. </item>
                              </list>
                              <content styleCode="bold">Keep AIMOVIG and all medicines out of the reach of children.</content>
                           </td>
                        </tr>
                        <tr styleCode="Botrule">
                           <td styleCode="Lrule Rrule" colspan="2">
                              <content styleCode="bold">General information about the safe and effective use of AIMOVIG.</content>
                              <br/>Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. <content styleCode="bold">Do not</content> use AIMOVIG for a condition for which it is not prescribed. <content styleCode="bold">Do not</content> give AIMOVIG to other people, even if they have the same symptoms that you have. It can harm them. You can ask your pharmacist or healthcare provider for information about AIMOVIG that is written for healthcare professionals. </td>
                        </tr>
                        <tr styleCode="Botrule">
                           <td styleCode="Lrule Rrule" colspan="2">
                              <content styleCode="bold">What are the ingredients in AIMOVIG?</content>
                              <list>
                                 <item>
                                    <content styleCode="bold">Active Ingredient:</content> erenumab-aooe</item>
                                 <item>
                                    <content styleCode="bold">Inactive Ingredients:</content> acetate, polysorbate 80, and sucrose</item>
                              </list>										AIMOVIG prefilled autoinjectors and prefilled syringes are not made with natural rubber latex. 									</td>
                        </tr>
                        <tr>
                           <td styleCode="Lrule Rrule" colspan="2">										AIMOVIG<sup>®</sup> (erenumab-aooe)<br/>
                              <content styleCode="bold">Manufactured by:</content>
                              <br/>Amgen Inc.<br/>One Amgen Center Drive<br/>Thousand Oaks, CA 91320-1799 U.S.A.<br/>U.S. License No. 1080<br/>Patent: http://pat.amgen.com/aimovig/<br/>© 2018-2025 Amgen Inc. All rights reserved.<br/>For more information, go to www.aimovig.com or call 1-800-77-AMGEN (1-800-772-6436).</td>
                        </tr>
                     </tbody>
                  </table>
               </text>
               <effectiveTime value="20250331"/>
            </section>
         </component>
         <component>
            <section>
               <id root="2291b03b-0b67-4db1-865b-9c9ef893d516"/>
               <code code="59845-8" codeSystem="2.16.840.1.113883.6.1" displayName="INSTRUCTIONS FOR USE SECTION"/>
               <title>INSTRUCTIONS FOR USE<br/>AIMOVIG<sup>®</sup> (AIM-oh-vig)<br/>(erenumab-aooe)<br/>injection, for subcutaneous use<br/>70 mg/mL<br/>single-dose prefilled SureClick<sup>®</sup> autoinjector</title>
               <text>
                  <paragraph>This Instructions for Use contains information on how to inject AIMOVIG with a SureClick autoinjector.</paragraph>
                  <paragraph>If your healthcare provider decides that you or a caregiver may be able to give your injections of AIMOVIG at home, you should receive training on the right way to prepare and inject AIMOVIG. Do not try to inject yourself until you have been shown the right way to give the injections by your healthcare provider or nurse.</paragraph>
                  <paragraph>The medicine in the AIMOVIG autoinjector is for injection under the skin (subcutaneous injection). See the AIMOVIG Patient Information for information about AIMOVIG.</paragraph>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="center" valign="top"/>
                     <tbody>
                        <tr>
                           <td>Getting to know your prefilled autoinjector<renderMultiMedia referencedObject="MM7"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td align="left">
                              <content styleCode="bold">1. Important Information You Need to Know Before Injecting AIMOVIG</content>
                              <list listType="unordered" styleCode="disc">
                                 <item>It is important that you do not try to give the injection until you have fully read and understood this Instructions for Use.</item>
                                 <item>
                                    <content styleCode="bold">Do not</content> use the autoinjector if the carton is damaged or the seal is broken.</item>
                                 <item>
                                    <content styleCode="bold">Do not</content> use the autoinjector after the expiration date on the label.</item>
                                 <item>
                                    <content styleCode="bold">Do not</content> shake the autoinjector.</item>
                                 <item>
                                    <content styleCode="bold">Do not</content> remove the white cap from the autoinjector until you are ready to inject.</item>
                                 <item>
                                    <content styleCode="bold">Do not</content> use the autoinjector if it has been frozen.</item>
                                 <item>
                                    <content styleCode="bold">Do not</content> use the autoinjector if it has been dropped on a hard surface. Part of the autoinjector may be broken even if you cannot see the break. Use a new autoinjector, and call 1-800-77-AMGEN (1-800-772-6436).</item>
                                 <item>The autoinjector is not made with natural rubber latex.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td align="left">
                              <content styleCode="bold">Frequently asked questions:</content>
                              <br/>For additional information and answers to frequently asked questions, visit <content styleCode="bold">www.aimovig.com</content>.</td>
                        </tr>
                        <tr styleCode="Botrule">
                           <td align="left">
                              <content styleCode="bold">Where to get help:</content>
                              <br/>If you want more information or help using AIMOVIG: 									<list listType="unordered" styleCode="disc">
                                 <item>Contact your healthcare provider,</item>
                                 <item>Visit <content styleCode="bold">www.aimovig.com</content>, or</item>
                                 <item>Call 1-800-77-AMGEN (1-800-772-6436)</item>
                              </list>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">2. Storing and Preparing to Inject AIMOVIG</content>
                  </paragraph>
                  <renderMultiMedia referencedObject="MM8"/>
                  <paragraph>
                     <content styleCode="bold">2a	Refrigerate the autoinjector carton until you are ready to use it.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>Keep the autoinjector in the refrigerator between 36°F to 46°F (2°C to 8°C).</item>
                     <item>Keep the autoinjector in the original carton to protect it from light or physical damage.</item>
                     <item>
                        <content styleCode="bold">Do not</content> freeze the autoinjector.</item>
                     <item>
                        <content styleCode="bold">Do not</content> store the autoinjector in extreme heat or cold. For example, avoid storing in your vehicle's glove box or trunk.</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr>
                           <td styleCode="Lrule Toprule Botrule Rrule">
                              <content styleCode="bold">Important:</content> Keep the autoinjector and all medicines out of the sight and reach of children.</td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr>
                           <td align="center">
                              <content styleCode="bold">WAIT</content>
                              <renderMultiMedia referencedObject="MM9"/>
                           </td>
                        </tr>
                        <tr styleCode="Botrule">
                           <td>
                              <content styleCode="bold">2b	Wait 30 minutes for the autoinjector to reach room temperature.</content>
                              <list listType="unordered" styleCode="disc">
                                 <item>Let the autoinjector warm up naturally.</item>
                                 <item>
                                    <content styleCode="bold">Do not</content> heat the autoinjector with hot water, a microwave, or direct sunlight.</item>
                                 <item>
                                    <content styleCode="bold">Do not</content> shake the autoinjector at any time.</item>
                                 <item>Using the autoinjector at room temperature makes sure the full dose is delivered and allows for a more comfortable injection.</item>
                              </list>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <renderMultiMedia referencedObject="MM10"/>
                  <paragraph>
                     <content styleCode="bold">2c	You may keep AIMOVIG at room temperature for up to 7 days, if needed.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>For example, when you are traveling, you may keep AIMOVIG at room temperature. 							<list listType="unordered" styleCode="disc">
                           <item>Keep it at room temperature between 68°F to 77°F (20°C to 25°C).</item>
                           <item>
                              <content styleCode="bold">Do not</content> put it back in the refrigerator.</item>
                           <item>Record the date you removed it from the refrigerator and use it within <content styleCode="bold">7</content> days.</item>
                        </list>
                     </item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr>
                           <td styleCode="Lrule Rrule Toprule Botrule">
                              <content styleCode="bold">Important:</content> Place the autoinjector in a sharps disposal container if it has reached room temperature and has not been used within <content styleCode="bold">7</content> days.</td>
                        </tr>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <renderMultiMedia referencedObject="MM11"/>
                  <paragraph>
                     <content styleCode="bold">2d	Inspect the medicine. It should be clear and colorless to slightly yellow.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>It is okay to see air bubbles in the autoinjector.</item>
                     <item>
                        <content styleCode="bold">Do not</content> use AIMOVIG if the medicine is cloudy, discolored, or has flakes or particles.</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr>
                           <td styleCode="Lrule Rrule Toprule Botrule">
                              <content styleCode="bold">Important:</content> If the medicine is cloudy, discolored, or has flakes or particles, or if the autoinjector is damaged or expired, call 1-800-77-AMGEN (1-800-772-6436).</td>
                        </tr>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <renderMultiMedia referencedObject="MM12"/>
                  <paragraph>
                     <content styleCode="bold">2e	Check the expiration date (Exp.) and inspect the autoinjector for damage.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>
                        <content styleCode="bold">Do not</content> use the autoinjector if the expiration date has passed.</item>
                     <item>
                        <content styleCode="bold">Do not</content> use the autoinjector if: 							<list listType="unordered" styleCode="disc">
                           <item>the white cap is missing or loose.</item>
                           <item>it has cracks or broken parts.</item>
                           <item>it has been dropped on a hard surface.</item>
                        </list>
                     </item>
                     <item>Make sure you have the right medicine and dose.</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">3. Getting Ready for Your Injection</content>
                  </paragraph>
                  <renderMultiMedia referencedObject="MM13"/>
                  <paragraph>
                     <content styleCode="bold">3a	Gather and place the following items for your injection on a clean, flat, and well-lit surface:</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>AIMOVIG autoinjector (room temperature)</item>
                     <item>Sharps disposal container [see Disposing of AIMOVIG and Checking the Injection Site]</item>
                     <item>Alcohol wipe</item>
                     <item>Adhesive bandage</item>
                     <item>Cotton ball or gauze pad</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <renderMultiMedia referencedObject="MM14"/>
                  <paragraph>
                     <content styleCode="bold">3b	Inject into 1 of these sites.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>Inject into the front of your thigh or stomach (except for 2 inches around your belly button).</item>
                     <item>Someone else can inject in your thigh, stomach, or back of the upper arm.</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr>
                           <td styleCode="Lrule Rrule Botrule Toprule">
                              <content styleCode="bold">Important:</content> Avoid areas with scars or stretch marks, or where the skin is tender, bruised, red, hard, raised, thick or scaly skin patch or lesion.</td>
                        </tr>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <renderMultiMedia referencedObject="MM15"/>
                  <paragraph>
                     <content styleCode="bold">3c Wash hands thoroughly with soap and water.</content>
                  </paragraph>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <renderMultiMedia referencedObject="MM16"/>
                  <paragraph>
                     <content styleCode="bold">3d	Clean the injection site with an alcohol wipe.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>Let the skin dry on its own.</item>
                     <item>
                        <content styleCode="bold">Do not</content> touch this area again before injecting.</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">4. Injecting AIMOVIG</content>
                  </paragraph>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr>
                           <td styleCode="Lrule Rrule Botrule Toprule">
                              <content styleCode="bold">Important:</content> Only remove the white cap when you can inject right away (within 5 minutes) because the medicine can dry out. <content styleCode="bold">Do not</content> recap.</td>
                        </tr>
                     </tbody>
                  </table>
                  <renderMultiMedia referencedObject="MM17"/>
                  <paragraph>
                     <content styleCode="bold">4a	Grasp the autoinjector so you can see the window. Pull the white cap straight off. You may need to pull hard.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>
                        <content styleCode="bold">Do not</content> twist, bend or wiggle the white cap to pull it off.</item>
                     <item>
                        <content styleCode="bold">Never</content> put the white cap back on. It may damage the needle.</item>
                     <item>
                        <content styleCode="bold">Do not</content> put your finger inside the dark green safety guard.</item>
                     <item>It is normal to see a drop of medicine at the end of the needle or dark green safety guard.</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <renderMultiMedia referencedObject="MM18"/>
                  <paragraph>
                     <content styleCode="bold">4b	Stretch or pinch the skin to create a firm surface at the injection site. Place the dark green safety guard straight against the skin.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>Keep the skin <content styleCode="bold">stretched or pinched</content> until the injection is finished.</item>
                     <item>Make sure you can see the window.</item>
                     <item>Make sure the autoinjector is positioned straight on the injection site (at a 90-degree angle).</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="center" valign="top"/>
                     <tbody>
                        <tr>
                           <td>
                              <content styleCode="bold">PUSH<br/>and hold against skin</content>
                              <renderMultiMedia referencedObject="MM19"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">4c	Firmly push the autoinjector down until the dark green safety guard stops moving. Hold the autoinjector down, do not lift.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>The dark green safety guard pushes in and unlocks the purple start button.</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="center" valign="top"/>
                     <tbody>
                        <tr>
                           <td>
                              <content styleCode="bold">PRESS<br/>purple start button</content>
                              <renderMultiMedia referencedObject="MM20"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">4d	Keep pushing the autoinjector down and press the purple start button to start the injection.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>You may hear or feel a click.</item>
                     <item>The window starts to turn yellow.</item>
                     <item>It is okay to let go of the purple start button.</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="center" valign="top"/>
                     <tbody>
                        <tr>
                           <td>
                              <content styleCode="bold">WATCH and CONFIRM<br/>that the window turns fully yellow</content>
                              <renderMultiMedia referencedObject="MM21"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">4e	Keep pushing the autoinjector down. When the window is fully yellow, the injection is complete.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>The injection may take up to <content styleCode="bold">15</content> seconds to complete.</item>
                     <item>You may hear or feel a click.</item>
                     <item>Lift the autoinjector away from your skin.</item>
                     <item>The dark green safety guard locks around the needle.</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr>
                           <td styleCode="Lrule Rrule Toprule Botrule">
                              <content styleCode="bold">Important:</content> If the window has not turned fully yellow, or it looks like the medicine is still coming out, you have not received a full dose. Call your healthcare provider right away.</td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">5. Disposing of AIMOVIG and Checking the Injection Site</content>
                  </paragraph>
                  <renderMultiMedia referencedObject="MM22"/>
                  <paragraph>
                     <content styleCode="bold">5a	Place the used autoinjector and white cap in an FDA-cleared sharps disposal container right away after use.</content>
                  </paragraph>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr>
                           <td styleCode="Lrule Rrule Toprule Botrule">
                              <content styleCode="bold">Important</content>: Do not throw away the autoinjector in your household trash.</td>
                        </tr>
                     </tbody>
                  </table>
                  <list listType="unordered" styleCode="disc">
                     <item>
                        <content styleCode="bold">Do not</content> reuse the autoinjector.</item>
                     <item>
                        <content styleCode="bold">Do not</content> touch the dark green safety guard.</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <renderMultiMedia referencedObject="MM23"/>
                  <paragraph>
                     <content styleCode="bold">5b	Check the injection site.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>
                        <content styleCode="bold">Do not</content> rub the injection site.</item>
                     <item>If there is blood, press a cotton ball or gauze pad on your injection site. Apply an adhesive bandage if necessary.</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">Additional information about your sharps disposal container<br/>If you do not have an FDA-cleared sharps disposal container, you may use a household container that is:</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>made of a heavy-duty plastic,</item>
                     <item>can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out,</item>
                     <item>upright and stable during use,</item>
                     <item>leak-resistant, and</item>
                     <item>properly labeled to warn of hazardous waste inside the container.</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Disposing of sharps disposal containers:</content>
                     <br/>When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container.</paragraph>
                  <paragraph>There may be state or local laws about how you should throw away used needles and syringes.</paragraph>
                  <paragraph>For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA's website at:</paragraph>
                  <paragraph>
                     <content styleCode="bold">http://www.fda.gov/safesharpsdisposal</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Do not dispose of your used sharps disposal container in your household trash</content> unless your community guidelines permit this.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Do not recycle your used sharps disposal container.</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Important: Keep the autoinjector and sharps disposal container out of the sight and reach of children.</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">For more information or help call 1-800-77-AMGEN (1-800-772-6436).</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">AIMOVIG<sup>®</sup> (AIM-oh-vig)</content>
                  </paragraph>
                  <paragraph>Manufactured by:<br/>Amgen Inc.<br/>One Amgen Center Drive<br/>Thousand Oaks, California 91320-1799<br/>US License Number 1080<br/>© 2018 - 2024 Amgen Inc.<br/>All rights reserved.<br/>Nnnnnnnnnn</paragraph>
                  <paragraph>
                     <content styleCode="bold">This Instructions for Use has been approved by the U.S. Food and Drug Administration.</content>
                  </paragraph>
                  <paragraph>Revised: 8/2024<br/>v11</paragraph>
               </text>
               <effectiveTime value="20250331"/>
               <component>
                  <observationMedia ID="MM7">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-07.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM8">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-08.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM9">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-09.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM10">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-10.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM11">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-11.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM12">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-12.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM13">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-13.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM14">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-14.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM15">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-15.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM16">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-16.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM17">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-17.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM18">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-18.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM19">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-19.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM20">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-20.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM21">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-21.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM22">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-22.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM23">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-23.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="28078fa2-566f-4c98-90bd-777fc0d5c4f3"/>
               <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
               <title>REFERENCE GUIDE </title>
               <text>
                  <table width="70%" styleCode="Noautorules">
                     <col width="10%" align="center" valign="middle"/>
                     <col width="50%" align="left" valign="middle"/>
                     <col width="40%" align="center" valign="middle"/>
                     <tbody>
                        <tr>
                           <td styleCode="Lrule Rrule Toprule Botrule" rowspan="2">
                              <content styleCode="bold">Side 1</content>
                           </td>
                           <td styleCode="Rrule Toprule Botrule" rowspan="2">
                              <content styleCode="bold">Reference Guide</content>
                              <br/>Aimovig<sup>®</sup> (AIM-oh-vig) <br/>(erenumab-aooe)<br/>injection, for subcutaneous use <br/>Single-Dose Prefilled SureClick<sup>®</sup> Autoinjector <br/>70 mg/mL </td>
                           <td styleCode="Rrule Toprule Botrule">
                              <content styleCode="bold">Read all instructions in carton before use.</content>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <content styleCode="bold">Questions? Call 1-800-77-AMGEN <br/> (1-800-772-6436)</content>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="30%" align="center" valign="middle"/>
                     <col width="5%" align="center" valign="middle"/>
                     <col width="25%" align="center" valign="middle"/>
                     <col width="5%" align="center" valign="middle"/>
                     <col width="18%" align="center" valign="middle"/>
                     <col width="17%" align="center" valign="middle"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td styleCode="Lrule Rrule Toprule Botrule">
                              <content styleCode="bold">Guide to parts</content>
                           </td>
                           <td styleCode="Rrule Toprule Botrule" colspan="2" rowspan="3" valign="middle" align="left">
                              <content styleCode="bold">Wait at least 30 minutes</content> for the autoinjector to come to room temperature before giving your injection.</td>
                           <td styleCode="Rrule Toprule Botrule" colspan="3" rowspan="2" align="left">Pull the white cap straight off only when you are ready to inject. <content styleCode="bold">Do not</content> leave the white cap off for <content styleCode="bold">more than 5 minutes</content>. This can dry out the medicine.</td>
                        </tr>
                        <tr styleCode="Botrule">
                           <td styleCode="Lrule Rrule" rowspan="7">
                              <renderMultiMedia referencedObject="MM24"/>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Botrule">
                              <content styleCode="bold">2</content>
                           </td>
                           <td styleCode="Rrule" colspan="2"> </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Botrule" colspan="2"> </td>
                           <td> </td>
                           <td styleCode="Rrule Botrule" colspan="2" rowspan="4">
                              <renderMultiMedia referencedObject="MM25"/>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Botrule" colspan="2" align="left">Prepare and clean your injection site.</td>
                           <td/>
                        </tr>
                        <tr>
                           <td styleCode="Lrule Rrule Botrule">
                              <content styleCode="bold">1</content>
                           </td>
                           <td styleCode="Rrule Botrule" rowspan="3">
                              <renderMultiMedia referencedObject="MM26"/>
                           </td>
                           <td> </td>
                        </tr>
                        <tr>
                           <td> </td>
                           <td styleCode="Botrule"> </td>
                        </tr>
                        <tr>
                           <td styleCode="Botrule"> </td>
                           <td styleCode="Rrule" colspan="2"> </td>
                           <td styleCode="Rrule Botrule" align="right">
                              <content styleCode="bold">Turn over to continue</content>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="5%" align="left" valign="middle"/>
                     <col width="5%" align="left" valign="middle"/>
                     <col width="15%" align="left" valign="middle"/>
                     <col width="5%" align="left" valign="middle"/>
                     <col width="20%" align="left" valign="middle"/>
                     <col width="5%" align="left" valign="middle"/>
                     <col width="20%" align="left" valign="middle"/>
                     <col width="5%" align="left" valign="middle"/>
                     <col width="20%" align="left" valign="middle"/>
                     <tbody>
                        <tr>
                           <td styleCode="Lrule Rrule Toprule" colspan="2" rowspan="2">
                              <content styleCode="bold">Side 2</content>
                           </td>
                           <td styleCode="Rrule Toprule" colspan="3" rowspan="2">
                              <content styleCode="bold">Reference Guide</content>
                              <br/>Aimovig<sup>®</sup> (AIM-oh-vig) (erenumab-aooe) <br/>injection, for subcutaneous use <br/>Single-Dose Prefilled SureClick<sup>®</sup> Autoinjector <br/>70 mg/mL</td>
                           <td styleCode="Rrule" colspan="2">
                              <content styleCode="bold">AMGEN</content>
                           </td>
                           <td styleCode="Lrule Rrule Toprule Botrule" colspan="2" align="right">
                              <content styleCode="bold">Read other side first </content>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Botrule" colspan="4">
                              <paragraph>Manufactured by: <br/>Amgen, Inc. <br/>Thousand Oaks, CA 91320<br/>© 2020-2022, 2024 Amgen Inc. All rights reserved.<br/>
                                 <renderMultiMedia referencedObject="MM27"/>This printed material is recyclable. <br/>&lt;part number&gt; Revised: 8/2024 v4</paragraph>
                           </td>
                        </tr>
                        <tr styleCode="Botrule">
                           <td styleCode="Lrule Rrule Toprule" colspan="3">Stretch <content styleCode="bold">or</content> pinch your injection site to create a firm surface.</td>
                           <td styleCode="Rrule Toprule" colspan="2">
                              <content styleCode="bold">Put</content> the green safety guard (needle inside) on your skin at 90 degrees.</td>
                           <td styleCode="Rrule Toprule" colspan="2">Firmly<content styleCode="bold"> push </content>down the autoinjector onto your skin until it stops moving.</td>
                           <td styleCode="Rrule Toprule" colspan="2">Keep <content styleCode="bold">pushing</content> down on your skin for <content styleCode="bold">about 15 seconds.</content>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Lrule Rrule Toprule Botrule">
                              <content styleCode="bold">3</content>
                           </td>
                           <td colspan="2" styleCode="Rrule"/>
                           <td styleCode="Rrule Botrule">
                              <content styleCode="bold">4</content>
                           </td>
                           <td styleCode="Rrule"/>
                           <td styleCode="Rrule Botrule">
                              <content styleCode="bold">5</content>
                           </td>
                           <td styleCode="Rrule"/>
                           <td styleCode="Rrule Botrule">
                              <content styleCode="bold">6</content>
                           </td>
                           <td styleCode="Rrule"/>
                        </tr>
                        <tr>
                           <td styleCode="Lrule Rrule Botrule" colspan="3">
                              <renderMultiMedia referencedObject="MM28"/>
                           </td>
                           <td colspan="2" styleCode="Rrule Botrule">
                              <renderMultiMedia referencedObject="MM29"/>
                           </td>
                           <td styleCode="Rrule Botrule" colspan="2">When you are ready to inject, <content styleCode="bold">press</content> the purple start button. You will hear a click.<br/>"click"<br/>
                              <paragraph>
                                 <renderMultiMedia referencedObject="MM30"/>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule Botrule" colspan="2">
                              <paragraph>
                                 <renderMultiMedia referencedObject="MM31"/>
                                 <br/>
                                 <content styleCode="bold"> 15 seconds</content>
                                 <br/>Window turns from clear to yellow when the injection is done.<br/>"click"<br/>
                                 <renderMultiMedia referencedObject="MM32"/>
                              </paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
               </text>
               <effectiveTime value="20250331"/>
               <component>
                  <observationMedia ID="MM24">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-24.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM25">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-25.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM26">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-26.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM27">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-27.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM28">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-28.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM29">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-29.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM30">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-30.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM31">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-31.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM32">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-32.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="d2801a4d-2685-4894-aab7-fefbea7175d4"/>
               <code code="59845-8" codeSystem="2.16.840.1.113883.6.1" displayName="INSTRUCTIONS FOR USE SECTION"/>
               <title>INSTRUCTIONS FOR USE<br/>AIMOVIG<sup>®</sup> (AIM-oh-vig)<br/>(erenumab-aooe)<br/>injection, for subcutaneous use<br/>140 mg/mL<br/>single-dose prefilled SureClick<sup>®</sup> autoinjector</title>
               <text>
                  <paragraph>This Instructions for Use contains information on how to inject AIMOVIG with a SureClick autoinjector.</paragraph>
                  <paragraph>If your healthcare provider decides that you or a caregiver may be able to give your injections of AIMOVIG at home, you should receive training on the right way to prepare and inject AIMOVIG. Do not try to inject yourself until you have been shown the right way to give the injections by your healthcare provider or nurse.</paragraph>
                  <paragraph>The medicine in the AIMOVIG autoinjector is for injection under the skin (subcutaneous injection). See the AIMOVIG Patient Information for information about AIMOVIG.</paragraph>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="center" valign="top"/>
                     <tbody>
                        <tr>
                           <td>Getting to know your prefilled autoinjector<renderMultiMedia referencedObject="MM33"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td align="left">
                              <content styleCode="bold">1. Important Information You Need to Know Before Injecting AIMOVIG</content>
                              <list listType="unordered" styleCode="disc">
                                 <item>It is important that you do not try to give the injection until you have fully read and understood this Instructions for Use.</item>
                                 <item>
                                    <content styleCode="bold">Do not</content> use the autoinjector if the carton is damaged or the seal is broken.</item>
                                 <item>
                                    <content styleCode="bold">Do not</content> use the autoinjector after the expiration date on the label.</item>
                                 <item>
                                    <content styleCode="bold">Do not</content> shake the autoinjector.</item>
                                 <item>
                                    <content styleCode="bold">Do not</content> remove the orange cap from the autoinjector until you are ready to inject.</item>
                                 <item>
                                    <content styleCode="bold">Do not</content> use the autoinjector if it has been frozen.</item>
                                 <item>
                                    <content styleCode="bold">Do not</content> use the autoinjector if it has been dropped on a hard surface. Part of the autoinjector may be broken even if you cannot see the break. Use a new autoinjector, and call 1-800-77-AMGEN (1-800-772-6436).</item>
                                 <item>The autoinjector is not made with natural rubber latex.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td align="left">
                              <content styleCode="bold">Frequently asked questions:</content>
                              <br/>For additional information and answers to frequently asked questions, visit <content styleCode="bold">www.aimovig.com</content>.</td>
                        </tr>
                        <tr styleCode="Botrule">
                           <td align="left">
                              <content styleCode="bold">Where to get help:</content>
                              <br/>If you want more information or help using AIMOVIG: 									<list listType="unordered" styleCode="disc">
                                 <item>Contact your healthcare provider,</item>
                                 <item>Visit <content styleCode="bold">www.aimovig.com</content>, or</item>
                                 <item>Call 1-800-77-AMGEN (1-800-772-6436)</item>
                              </list>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">2. Storing and Preparing to Inject AIMOVIG</content>
                  </paragraph>
                  <renderMultiMedia referencedObject="MM34"/>
                  <paragraph>
                     <content styleCode="bold">2a	Refrigerate the autoinjector carton until you are ready to use it.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>Keep the autoinjector in the refrigerator between 36°F to 46°F (2°C to 8°C).</item>
                     <item>Keep the autoinjector in the original carton to protect it from light or physical damage.</item>
                     <item>
                        <content styleCode="bold">Do not</content> freeze the autoinjector.</item>
                     <item>
                        <content styleCode="bold">Do not</content> store the autoinjector in extreme heat or cold. For example, avoid storing in your vehicle's glove box or trunk.</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr>
                           <td styleCode="Lrule Rrule Toprule Botrule">
                              <content styleCode="bold">Important:</content> Keep the autoinjector and all medicines out of the sight and reach of children.</td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="center" valign="top"/>
                     <tbody>
                        <tr>
                           <td>
                              <content styleCode="bold">WAIT</content>
                              <renderMultiMedia referencedObject="MM35"/>
                           </td>
                        </tr>
                        <tr styleCode="Botrule">
                           <td align="left">
                              <content styleCode="bold">2b	Wait 30 minutes for the autoinjector to reach room temperature.</content>
                              <list listType="unordered" styleCode="disc">
                                 <item>Let the autoinjector warm up naturally.</item>
                                 <item>
                                    <content styleCode="bold">Do not</content> heat the autoinjector with hot water, a microwave, or direct sunlight.</item>
                                 <item>
                                    <content styleCode="bold">Do not</content> shake the autoinjector at any time.</item>
                                 <item>Using the autoinjector at room temperature makes sure the full dose is delivered and allows for a more comfortable injection.</item>
                              </list>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <renderMultiMedia referencedObject="MM36"/>
                  <paragraph>
                     <content styleCode="bold">2c You may keep AIMOVIG at room temperature for up to 7 days, if needed.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>For example, when you are traveling, you may keep AIMOVIG at room temperature. 							<list listType="unordered" styleCode="disc">
                           <item>Keep it at room temperature between 68°F to 77°F (20°C to 25°C).</item>
                           <item>
                              <content styleCode="bold">Do not</content> put it back in the refrigerator.</item>
                           <item>Record the date you removed it from the refrigerator and use it within <content styleCode="bold">7</content> days.</item>
                        </list>
                     </item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr>
                           <td styleCode="Lrule Rrule Toprule Botrule">
                              <content styleCode="bold">Important:</content> Place the autoinjector in a sharps disposal container if it has reached room temperature and has not been used within <content styleCode="bold">7</content> days.</td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <renderMultiMedia referencedObject="MM37"/>
                  <paragraph>
                     <content styleCode="bold">2d	Inspect the medicine. It should be clear and colorless to slightly yellow.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>It is okay to see air bubbles in the autoinjector.</item>
                     <item>
                        <content styleCode="bold">Do not</content> use AIMOVIG if the medicine is cloudy, discolored, or has flakes or particles.</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr>
                           <td styleCode="Lrule Rrule Toprule Botrule">
                              <content styleCode="bold">Important:</content> If the medicine is cloudy, discolored, or has flakes or particles, or if the autoinjector is damaged or expired, call 1-800-77-AMGEN (1-800-772-6436).</td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <renderMultiMedia referencedObject="MM38"/>
                  <paragraph>
                     <content styleCode="bold">2e	Check the expiration date (Exp.) and inspect the autoinjector for damage.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>
                        <content styleCode="bold">Do not</content> use the autoinjector if the expiration date has passed.</item>
                     <item>
                        <content styleCode="bold">Do not</content> use the autoinjector if: 							<list listType="unordered" styleCode="disc">
                           <item>the orange cap is missing or loose.</item>
                           <item>it has cracks or broken parts.</item>
                           <item>it has been dropped on a hard surface.</item>
                        </list>
                     </item>
                     <item>Make sure you have the right medicine and dose.</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">3. Getting Ready for Your Injection</content>
                  </paragraph>
                  <renderMultiMedia referencedObject="MM39"/>
                  <paragraph>
                     <content styleCode="bold">3a	Gather and place the following items for your injection on a clean, flat, and well-lit surface:</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>AIMOVIG autoinjector (room temperature)</item>
                     <item>Sharps disposal container [see Disposing of AIMOVIG and Checking the Injection Site]</item>
                     <item>Alcohol wipe</item>
                     <item>Adhesive bandage</item>
                     <item>Cotton ball or gauze pad</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <renderMultiMedia referencedObject="MM40"/>
                  <paragraph>
                     <content styleCode="bold">3b	Inject into 1 of these sites.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>Inject into the front of your thigh or stomach (except for 2 inches around your belly button).</item>
                     <item>Someone else can inject in your thigh, stomach, or back of the upper arm.</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr>
                           <td styleCode="Lrule Rrule Toprule Botrule">
                              <content styleCode="bold">Important:</content> Avoid areas with scars or stretch marks, or where the skin is tender, bruised, red, hard, raised, thick or scaly skin patch or lesion.</td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <renderMultiMedia referencedObject="MM41"/>
                  <paragraph>
                     <content styleCode="bold">3c Wash hands thoroughly with soap and water.</content>
                  </paragraph>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <renderMultiMedia referencedObject="MM42"/>
                  <paragraph>
                     <content styleCode="bold">3d	Clean the injection site with an alcohol wipe.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>Let the skin dry on its own.</item>
                     <item>
                        <content styleCode="bold">Do not</content> touch this area again before injecting.</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">4. Injecting AIMOVIG</content>
                  </paragraph>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr>
                           <td styleCode="Lrule Rrule Toprule Botrule">
                              <content styleCode="bold">Important:</content> Only remove the orange cap when you can inject right away (within 5 minutes) because the medicine can dry out. <content styleCode="bold">Do not</content> recap.</td>
                        </tr>
                     </tbody>
                  </table>
                  <renderMultiMedia referencedObject="MM43"/>
                  <paragraph>
                     <content styleCode="bold">4a	Grasp the autoinjector so you can see the window. Pull the orange cap straight off. You may need to pull hard.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>
                        <content styleCode="bold">Do not</content> twist, bend or wiggle the orange cap to pull it off.</item>
                     <item>
                        <content styleCode="bold">Never</content> put the orange cap back on. It may damage the needle. </item>
                     <item>
                        <content styleCode="bold">Do not</content> put your finger inside the yellow safety guard.</item>
                     <item>It is normal to see a drop of medicine at the end of the needle or yellow safety guard.</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <renderMultiMedia referencedObject="MM44"/>
                  <paragraph>
                     <content styleCode="bold">4b	Stretch or pinch the skin to create a firm surface at the injection site. Place the yellow safety guard straight against the skin.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>Keep the skin <content styleCode="bold">stretched or pinched</content> until the injection is finished.</item>
                     <item>Make sure you can see the window.</item>
                     <item>Make sure the autoinjector is positioned straight on the injection site (at a 90-degree angle).</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="center" valign="top"/>
                     <tbody>
                        <tr>
                           <td>
                              <content styleCode="bold">PUSH<br/>and hold against skin</content>
                              <renderMultiMedia referencedObject="MM45"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">4c	Firmly push the autoinjector down until the yellow safety guard stops moving. Hold the autoinjector down, do not lift.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>The yellow safety guard pushes in and unlocks the gray start button.</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="center" valign="top"/>
                     <tbody>
                        <tr>
                           <td>
                              <content styleCode="bold">PRESS<br/>gray start button</content>
                              <renderMultiMedia referencedObject="MM46"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">4d	Keep pushing the autoinjector down and press the gray start button to start the injection.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>You may hear or feel a click.</item>
                     <item>The window starts to turn yellow.</item>
                     <item>It is okay to let go of the gray start button.</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="center" valign="top"/>
                     <tbody>
                        <tr>
                           <td>
                              <content styleCode="bold">WATCH and CONFIRM<br/>that the window turns fully yellow</content>
                              <renderMultiMedia referencedObject="MM47"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">4e	Keep pushing the autoinjector down. When the window is fully yellow, the injection is complete.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>The injection may take up to <content styleCode="bold">15</content> seconds to complete. </item>
                     <item>You may hear or feel a click.</item>
                     <item>Lift the autoinjector away from your skin.</item>
                     <item>The yellow safety guard locks around the needle.</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr>
                           <td styleCode="Lrule Rrule Toprule Botrule">
                              <content styleCode="bold">Important:</content> If the window has not turned fully yellow, or it looks like the medicine is still coming out, you have not received a full dose. Call your healthcare provider right away.</td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">5. Disposing of AIMOVIG and Checking the Injection Site</content>
                  </paragraph>
                  <renderMultiMedia referencedObject="MM48"/>
                  <paragraph>
                     <content styleCode="bold">5a	Place the used autoinjector and orange cap in an FDA-cleared sharps disposal container right away after use.</content>
                  </paragraph>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr>
                           <td styleCode="Lrule Rrule Toprule Botrule">
                              <content styleCode="bold">Important</content>: Do not throw away the autoinjector in your household trash.</td>
                        </tr>
                     </tbody>
                  </table>
                  <list listType="unordered" styleCode="disc">
                     <item>
                        <content styleCode="bold">Do not</content> reuse the autoinjector.</item>
                     <item>
                        <content styleCode="bold">Do not</content> touch the yellow safety guard.</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <renderMultiMedia referencedObject="MM49"/>
                  <paragraph>
                     <content styleCode="bold">5b	Check the injection site.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>
                        <content styleCode="bold">Do not</content> rub the injection site. </item>
                     <item>If there is blood, press a cotton ball or gauze pad on your injection site. Apply an adhesive bandage if necessary.</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="100%" align="left" valign="top"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td> </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">Additional information about your sharps disposal container<br/>If you do not have an FDA-cleared sharps disposal container, you may use a household container that is:</content>
                  </paragraph>
                  <list listType="unordered" styleCode="disc">
                     <item>made of a heavy-duty plastic,</item>
                     <item>can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out,</item>
                     <item>upright and stable during use,</item>
                     <item>leak-resistant, and</item>
                     <item>properly labeled to warn of hazardous waste inside the container.</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Disposing of sharps disposal containers:</content>
                     <br/>When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container.</paragraph>
                  <paragraph>There may be state or local laws about how you should throw away used needles and syringes.</paragraph>
                  <paragraph>For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA's website at:</paragraph>
                  <paragraph>
                     <content styleCode="bold">http://www.fda.gov/safesharpsdisposal</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Do not dispose of your used sharps disposal container in your household trash</content> unless your community guidelines permit this.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Do not recycle your used sharps disposal container.</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Important: Keep the autoinjector and sharps disposal container out of the sight and reach of children.</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">For more information or help call 1-800-77-AMGEN (1-800-772-6436).</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">AIMOVIG<sup>®</sup> (AIM-oh-vig)</content>
                  </paragraph>
                  <paragraph>Manufactured by:<br/>Amgen Inc.<br/>One Amgen Center Drive<br/>Thousand Oaks, California 91320-1799<br/>U.S. License Number 1080<br/>© 2019 - 2024 Amgen Inc. All rights reserved.<br/>nnnnnnnnnn </paragraph>
                  <paragraph>
                     <content styleCode="bold">This Instructions for Use has been approved by the U.S. Food and Drug Administration.</content>
                  </paragraph>
                  <paragraph>Revised: 8/2024<br/>v10</paragraph>
               </text>
               <effectiveTime value="20250331"/>
               <component>
                  <observationMedia ID="MM33">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-33.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM34">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-34.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM35">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-35.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM36">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-36.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM37">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-37.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM38">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-38.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM39">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-39.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM40">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-40.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM41">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-41.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM42">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-42.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM43">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-43.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM44">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-44.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM45">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-45.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM46">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-46.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM47">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-47.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM48">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-48.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM49">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-49.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="4e30e2d2-9703-4d64-b463-2ebb2e83b13a"/>
               <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
               <title>REFERENCE GUIDE </title>
               <text>
                  <table width="70%" styleCode="Noautorules">
                     <col width="10%" align="center" valign="middle"/>
                     <col width="50%" align="left" valign="middle"/>
                     <col width="40%" align="center" valign="middle"/>
                     <tbody>
                        <tr>
                           <td styleCode="Lrule Rrule Toprule Botrule" rowspan="2">
                              <content styleCode="bold">Side 1</content>
                           </td>
                           <td styleCode="Rrule Toprule Botrule" rowspan="2">
                              <content styleCode="bold">Reference Guide</content>
                              <br/>Aimovig<sup>®</sup> (AIM-oh-vig) <br/>(erenumab-aooe)<br/>injection, for subcutaneous use <br/>Single-Dose Prefilled SureClick<sup>®</sup> Autoinjector <br/>140 mg/mL </td>
                           <td styleCode="Rrule Toprule Botrule">
                              <content styleCode="bold">Read all instructions in carton before use.</content>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <content styleCode="bold">Questions? Call 1-800-77-AMGEN <br/> (1-800-772-6436)</content>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="30%" align="center" valign="middle"/>
                     <col width="5%" align="center" valign="middle"/>
                     <col width="25%" align="center" valign="middle"/>
                     <col width="5%" align="center" valign="middle"/>
                     <col width="18%" align="center" valign="middle"/>
                     <col width="17%" align="center" valign="middle"/>
                     <tbody>
                        <tr styleCode="Botrule">
                           <td styleCode="Lrule Rrule Toprule Botrule">
                              <content styleCode="bold">Guide to parts</content>
                           </td>
                           <td styleCode="Rrule Toprule Botrule" colspan="2" rowspan="3" valign="middle" align="left">
                              <content styleCode="bold">Wait at least 30 minutes</content> for the autoinjector to come to room temperature before giving your injection.</td>
                           <td styleCode="Rrule Toprule Botrule" colspan="3" rowspan="2" align="left">Pull the orange cap straight off only when you are ready to inject. <content styleCode="bold">Do not</content> leave the orange cap off for <content styleCode="bold">more than 5 minutes</content>. This can dry out the medicine.</td>
                        </tr>
                        <tr styleCode="Botrule">
                           <td styleCode="Lrule Rrule" rowspan="7">
                              <renderMultiMedia referencedObject="MM50"/>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Botrule">
                              <content styleCode="bold">2</content>
                           </td>
                           <td styleCode="Rrule" colspan="2"> </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Botrule" colspan="2"> </td>
                           <td> </td>
                           <td styleCode="Rrule Botrule" colspan="2" rowspan="4">
                              <renderMultiMedia referencedObject="MM51"/>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Botrule" colspan="2" align="left">Prepare and clean your injection site.</td>
                           <td/>
                        </tr>
                        <tr>
                           <td styleCode="Lrule Rrule Botrule">
                              <content styleCode="bold">1</content>
                           </td>
                           <td styleCode="Rrule Botrule" rowspan="3">
                              <renderMultiMedia referencedObject="MM52"/>
                           </td>
                           <td> </td>
                        </tr>
                        <tr>
                           <td> </td>
                           <td styleCode="Botrule"> </td>
                        </tr>
                        <tr>
                           <td styleCode="Botrule"> </td>
                           <td styleCode="Rrule" colspan="2"> </td>
                           <td styleCode="Rrule Botrule" align="right">
                              <content styleCode="bold">Turn over to continue</content>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <table width="100%" styleCode="Noautorules">
                     <col width="5%" align="left" valign="middle"/>
                     <col width="5%" align="left" valign="middle"/>
                     <col width="15%" align="left" valign="middle"/>
                     <col width="5%" align="left" valign="middle"/>
                     <col width="20%" align="left" valign="middle"/>
                     <col width="5%" align="left" valign="middle"/>
                     <col width="20%" align="left" valign="middle"/>
                     <col width="5%" align="left" valign="middle"/>
                     <col width="20%" align="left" valign="middle"/>
                     <tbody>
                        <tr>
                           <td styleCode="Lrule Rrule Toprule" colspan="2" rowspan="2">
                              <content styleCode="bold">Side 2</content>
                           </td>
                           <td styleCode="Rrule Toprule" colspan="3" rowspan="2">
                              <content styleCode="bold">Reference Guide</content>
                              <br/>Aimovig<sup>®</sup> (AIM-oh-vig) (erenumab-aooe) <br/>injection, for subcutaneous use <br/>Single-Dose Prefilled SureClick<sup>®</sup> Autoinjector <br/>140 mg/mL</td>
                           <td styleCode="Rrule" colspan="2">
                              <content styleCode="bold">AMGEN</content>
                           </td>
                           <td styleCode="Lrule Rrule Toprule Botrule" colspan="2" align="right">
                              <content styleCode="bold">Read other side first </content>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Botrule" colspan="4">
                              <paragraph>Manufactured by: <br/>Amgen, Inc. <br/>Thousand Oaks, CA 91320<br/>© 2020-2022, 2024 Amgen Inc. All rights reserved.<br/>
                                 <renderMultiMedia referencedObject="MM53"/>This printed material is recyclable. <br/>&lt;part number&gt; Revised: 8/2024 v4</paragraph>
                           </td>
                        </tr>
                        <tr styleCode="Botrule">
                           <td styleCode="Lrule Rrule Toprule" colspan="3">Stretch <content styleCode="bold">or</content> pinch your injection site to create a firm surface.</td>
                           <td styleCode="Rrule Toprule" colspan="2">
                              <content styleCode="bold">Put</content> the yellow safety guard (needle inside) on your skin at 90 degrees.</td>
                           <td styleCode="Rrule Toprule" colspan="2">Firmly<content styleCode="bold"> push </content>down the autoinjector onto your skin until it stops moving.</td>
                           <td styleCode="Rrule Toprule" colspan="2">Keep <content styleCode="bold">pushing</content> down on your skin for <content styleCode="bold">about 15 seconds.</content>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Lrule Rrule Toprule Botrule">
                              <content styleCode="bold">3</content>
                           </td>
                           <td colspan="2" styleCode="Rrule"/>
                           <td styleCode="Rrule Botrule">
                              <content styleCode="bold">4</content>
                           </td>
                           <td styleCode="Rrule"/>
                           <td styleCode="Rrule Botrule">
                              <content styleCode="bold">5</content>
                           </td>
                           <td styleCode="Rrule"/>
                           <td styleCode="Rrule Botrule">
                              <content styleCode="bold">6</content>
                           </td>
                           <td styleCode="Rrule"/>
                        </tr>
                        <tr>
                           <td styleCode="Lrule Rrule Botrule" colspan="3">
                              <renderMultiMedia referencedObject="MM54"/>
                           </td>
                           <td colspan="2" styleCode="Rrule Botrule">
                              <renderMultiMedia referencedObject="MM55"/>
                           </td>
                           <td styleCode="Rrule Botrule" colspan="2">When you are ready to inject, <content styleCode="bold">press</content> the gray start button. You will hear a click.<br/>"click"<br/>
                              <paragraph>
                                 <renderMultiMedia referencedObject="MM56"/>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule Botrule" colspan="2">
                              <paragraph>
                                 <renderMultiMedia referencedObject="MM57"/>
                                 <br/> <content styleCode="bold">15 seconds</content>
                                 <br/>Window turns from clear to yellow when the injection is done.<br/>"click"<br/>
                                 <renderMultiMedia referencedObject="MM58"/>
                              </paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
               </text>
               <effectiveTime value="20250331"/>
               <component>
                  <observationMedia ID="MM50">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-50.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM51">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-51.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM52">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-52.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM53">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-53.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM54">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-54.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM55">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-55.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM56">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-56.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM57">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-57.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM58">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-58.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="3530291b-df29-4904-851c-89f8013ab97b"/>
               <code code="59845-8" codeSystem="2.16.840.1.113883.6.1" displayName="INSTRUCTIONS FOR USE SECTION"/>
               <title>Instructions for Use <br/>AIMOVIG<sup>®</sup> (AIM-oh-vig) (erenumab-aooe) <br/>Injection, For Subcutaneous Use <br/>Single-Dose Prefilled Syringe<br/>70 mg/mL and 140 mg/mL</title>
               <text>
                  <paragraph>
                     <renderMultiMedia referencedObject="MM59"/>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Important:</content> Needle is inside the gray needle cap.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Important</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Before you use AIMOVIG prefilled syringe, read this important information:</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Storing your AIMOVIG prefilled syringe</content>
                  </paragraph>
                  <list>
                     <item>Keep the syringe out of the reach of children.</item>
                     <item>Keep the syringe in the original carton to protect from light.</item>
                     <item>The syringe should be kept in the refrigerator at 36°F to 46°F (2°C to 8°C). </item>
                     <item>After removing AIMOVIG from the refrigerator, it can be stored at room temperature between 68°F to 77°F (20°C to 25°C) for up to 7 days.</item>
                     <item>Throw away AIMOVIG that has been left at room temperature for more than 7 days. </item>
                     <item>
                        <content styleCode="bold">Do not</content> freeze.</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Using your AIMOVIG prefilled syringe</content>
                  </paragraph>
                  <list>
                     <item>It is important that you do not try to give the injection unless you or your caregiver has received training from your healthcare provider.</item>
                     <item>
                        <content styleCode="bold">Do not</content> use a syringe after the expiration date on the label.</item>
                     <item>
                        <content styleCode="bold">Do not</content> shake the syringe.</item>
                     <item>
                        <content styleCode="bold">Do not</content> remove the gray needle cap from the syringe until you are ready to inject.</item>
                     <item>
                        <content styleCode="bold">Do not</content> use the syringe if it has been frozen.</item>
                     <item>
                        <content styleCode="bold">Do not</content> use a syringe if it has been dropped on a hard surface. Part of the syringe may be broken even if you cannot see the break. Use a new syringe, and call 1-800-77-AMGEN (1-800-772-6436). </item>
                     <item>The prefilled syringe is not made with natural rubber latex.</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Step 1: Prepare</content>
                  </paragraph>
                  <paragraph>AIMOVIG comes as a single-dose (1 time) prefilled syringe. Your healthcare provider will prescribe the dose that is best for you.</paragraph>
                  <paragraph>Before you inject, always check the label of your single-dose prefilled syringe to make sure you have the correct medicine and the correct dose of AIMOVIG.</paragraph>
                  <paragraph>
                     <content styleCode="bold">A</content>  Remove AIMOVIG prefilled syringe from the carton.</paragraph>
                  <paragraph>Grab the syringe barrel to remove the syringe from the tray.</paragraph>
                  <table width="75%" styleCode="Noautorules">
                     <col width="40%" align="left" valign="top"/>
                     <col width="10%" align="left" valign="top"/>
                     <col width="50%" align="left" valign="top"/>
                     <tbody>
                        <tr>
                           <td>
                              <paragraph>
                                 <renderMultiMedia referencedObject="MM60"/>
                              </paragraph>
                           </td>
                           <td/>
                           <td>
                              <paragraph>
                                 <renderMultiMedia referencedObject="MM61"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td>Place finger or thumb on edge of tray to secure it while you remove the syringe.</td>
                           <td/>
                           <td>          <content styleCode="bold">Grab Here</content>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>For safety reasons:</paragraph>
                  <list>
                     <item>
                        <content styleCode="bold">Do not</content> grab the plunger rod.</item>
                     <item>
                        <content styleCode="bold">Do not</content> grab the gray needle cap.</item>
                     <item>
                        <content styleCode="bold">Do not</content> remove the gray needle cap until you are ready to inject.</item>
                     <item>
                        <content styleCode="bold">Do not</content> remove the finger flange. This is part of the syringe.</item>
                  </list>
                  <paragraph>Leave the syringe at room temperature for at least <content styleCode="bold">30</content> minutes before injecting.</paragraph>
                  <list>
                     <item>
                        <content styleCode="bold">Do not</content> put the syringe back in the refrigerator after it has reached room temperature.</item>
                     <item>
                        <content styleCode="bold">Do not</content> try to warm the syringe by using a heat source such as hot water or microwave.</item>
                     <item>
                        <content styleCode="bold">Do not</content> leave the syringe in direct sunlight.</item>
                     <item>
                        <content styleCode="bold">Do not</content> shake the syringe.</item>
                  </list>
                  <paragraph>Important: Always hold the prefilled syringe by the syringe barrel.</paragraph>
                  <paragraph>
                     <content styleCode="bold">B</content> Inspect the AIMOVIG prefilled syringe.</paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="MM62"/>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Always hold the syringe by the syringe barrel.</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Make sure the medicine in the syringe is clear and colorless to slightly yellow.</content>
                  </paragraph>
                  <list>
                     <item>
                        <content styleCode="bold">Do not</content> use the syringe if the medicine is cloudy or discolored or contains flakes or particles.</item>
                     <item>
                        <content styleCode="bold">Do not</content> use the syringe if any part appears cracked or broken.</item>
                     <item>
                        <content styleCode="bold">Do not</content> use the syringe if the syringe has been dropped.</item>
                     <item>
                        <content styleCode="bold">Do not</content> use the syringe if the gray needle cap is missing or not securely attached.</item>
                     <item>
                        <content styleCode="bold">Do not</content> use the syringe if the expiration date printed on the label has passed.</item>
                  </list>
                  <paragraph>In all cases, use a new syringe, and call 1-800-77-AMGEN (1-800-772-6436).</paragraph>
                  <paragraph>
                     <content styleCode="bold">C</content>  Gather all materials needed for your injection.</paragraph>
                  <paragraph>Wash your hands thoroughly with soap and water.  </paragraph>
                  <paragraph>On a clean, well-lit work surface, place the:</paragraph>
                  <list>
                     <item>New syringe </item>
                     <item>Alcohol wipes</item>
                     <item>Cotton balls or gauze pads</item>
                     <item>Adhesive bandages</item>
                     <item>Sharps disposal container</item>
                  </list>
                  <paragraph>
                     <renderMultiMedia referencedObject="MM63"/>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">D</content>  Prepare and clean your injection site.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Only use these injection sites:</content>
                  </paragraph>
                  <list>
                     <item>Your thigh</item>
                     <item>Stomach area (abdomen), except for a <content styleCode="bold">two</content> inch area right around your navel</item>
                     <item>Outer area of upper arm (only if someone else is giving you the injection)</item>
                  </list>
                  <paragraph>Clean your injection site with an alcohol wipe. Let your skin dry.</paragraph>
                  <list>
                     <item>
                        <content styleCode="bold">Do not</content> touch this area again before injecting.</item>
                     <item>
                        <content styleCode="bold">Do not</content> inject into areas where the skin is tender, bruised, red, or hard. Avoid injecting directly into raised, thick, red, or scaly skin patch or lesion, or areas with scars or stretch marks.<br/>
                        <paragraph>
                           <renderMultiMedia referencedObject="MM64"/>
                        </paragraph>
                     </item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Step 2: Get ready</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">E</content>  Pull gray needle cap straight out and away from your body, only when you are ready to inject. <content styleCode="bold">Do not</content> leave the gray needle cap off for more than <content styleCode="bold">five minutes</content>. This can dry out the medicine.</paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="MM65"/>
                  </paragraph>
                  <paragraph>It is normal to see a drop of liquid at the end of the needle.</paragraph>
                  <list>
                     <item>
                        <content styleCode="bold">Do not</content> twist or bend the gray needle cap.</item>
                     <item>
                        <content styleCode="bold">Do not</content> put the gray needle cap back onto the syringe.</item>
                     <item>
                        <content styleCode="bold">Do not</content> remove the gray needle cap from the syringe until you are ready to inject.</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Important:</content> Throw the gray needle cap into the sharps disposal container.</paragraph>
                  <paragraph>
                     <content styleCode="bold">F</content>  Pinch your injection site to create a firm surface.</paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="MM66"/>
                  </paragraph>
                  <paragraph>Pinch skin firmly between your thumb and fingers, creating an area about <content styleCode="bold">two</content> inches wide.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Important:</content> Keep skin pinched while injecting.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Step 3: Inject</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">G</content>  Hold the pinch. With the gray needle cap off, insert the syringe into your skin at 45 to 90 degrees.</paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="MM67"/>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Do not</content> place your finger on the plunger rod while inserting the needle.</paragraph>
                  <paragraph>
                     <content styleCode="bold">H</content>  Place your finger on the plunger rod. Using slow and constant pressure, push the plunger rod all the way down until the prefilled syringe stops moving.</paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="MM68"/>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">I</content>  When done, release your thumb, and gently lift the syringe off of your skin.</paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="MM69"/>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Important: </content>When you remove the syringe, if it looks like the medicine is still in the syringe barrel, this means you have not received a full dose. Call your healthcare provider immediately.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Step 4: Finish</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">J</content>  Discard the used syringe and the gray needle cap. </paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="MM70"/>
                  </paragraph>
                  <paragraph>Put the used AIMOVIG syringe and gray needle cap in a FDA-cleared sharps disposal container right away after use. <content styleCode="bold">Do not</content> throw away (dispose of) the syringe in your household trash.</paragraph>
                  <paragraph>If you do not have a FDA-cleared sharps disposal container, you may use a household container that is:</paragraph>
                  <list>
                     <item>Made of a heavy-duty plastic</item>
                     <item>Can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out</item>
                     <item>Upright and stable during use</item>
                     <item>Leak-resistant</item>
                     <item>Properly labeled to warn of hazardous waste inside the container </item>
                  </list>
                  <paragraph>When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used needles and syringes. For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA's website at: http://www.fda.gov/safesharpsdisposal.</paragraph>
                  <list>
                     <item>
                        <content styleCode="bold">Do not</content> reuse the syringe.</item>
                     <item>
                        <content styleCode="bold">Do not</content> recycle the syringe or sharps disposal container or throw them into household trash.</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Important:</content> Always keep the sharps disposal container out of the reach of children.</paragraph>
                  <paragraph>
                     <content styleCode="bold">K</content>  Examine the injection site. </paragraph>
                  <paragraph>If there is blood, press a cotton ball or gauze pad on your injection site. <content styleCode="bold">Do not</content> rub the injection site. Apply an adhesive bandage if needed.</paragraph>
                  <paragraph>For more information, go to www.aimovig.com or call 1-800-77-AMGEN (1-800-772-6436).</paragraph>
                  <paragraph>AIMOVIG<sup>®</sup> (erenumab-aooe)</paragraph>
                  <paragraph>Manufactured by:<br/>Amgen Inc.<br/>One Amgen Center Drive<br/>Thousand Oaks, CA 91320-1799 USA<br/>U.S. License No. 1080</paragraph>
                  <paragraph>© 2018-2022, 2024 Amgen Inc. All rights reserved.</paragraph>
                  <table width="55%">
                     <caption>Symbol table</caption>
                     <col width="33%" align="center" valign="top"/>
                     <col width="33%" align="center" valign="top"/>
                     <col width="34%" align="center" valign="top"/>
                     <tbody>
                        <tr>
                           <td styleCode="Lrule Rrule">
                              <renderMultiMedia referencedObject="MM71"/>
                           </td>
                           <td styleCode="Rrule">
                              <renderMultiMedia referencedObject="MM72"/>
                           </td>
                           <td styleCode="Rrule">
                              <renderMultiMedia referencedObject="MM73"/>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Lrule Rrule">Do not reuse</td>
                           <td styleCode="Rrule">CAUTION, Prior to use, read the enclosed Instructions For Use for administration information and see package insert for full Prescribing Information</td>
                           <td styleCode="Rrule">Lot number</td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>This Instructions for Use has been approved by the U.S. Food and Drug Administration. <br/>Approved: 8/2024 <br/>[partnumber] v7</paragraph>
               </text>
               <effectiveTime value="20250331"/>
               <component>
                  <observationMedia ID="MM59">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-59.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM60">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-60.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM61">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-61.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM62">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-62.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM63">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-63.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM64">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-64.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM65">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-65.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM66">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-66.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM67">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-67.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM68">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-68.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM69">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-69.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM70">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-70.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM71">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-71.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM72">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-72.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM73">
                     <text>Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-73.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="e1c17690-d6bf-4792-87f0-dabbd253afef"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 70 mg/mL Syringe Carton</title>
               <text>
                  <paragraph>AMGEN<sup>®</sup>
                  </paragraph>
                  <paragraph>1 x 70 mg/mL Prefilled Syringe<br/>NDC 55513-840-01<br/>Rx Only</paragraph>
                  <paragraph>aimovig<sup>®</sup>
                     <br/>(erenumab-aooe)<br/>Injection</paragraph>
                  <paragraph>70<br/>mg/mL</paragraph>
                  <paragraph>70 mg/mL</paragraph>
                  <paragraph>Single-dose Prefilled Syringe</paragraph>
                  <paragraph>For Subcutaneous Use Only</paragraph>
                  <paragraph>Store refrigerated at 2°C to 8°C (36°F to 46°F) in original <br/>carton to protect from light. Do Not Freeze. Do Not Shake.</paragraph>
                  <paragraph>Before injecting, allow AIMOVIG to sit<br/>at room temperature for at least 30 minutes<br/>with cap on, protected from direct sunlight.</paragraph>
                  <paragraph>Keep out of the sight and reach of children.</paragraph>
                  <paragraph>For more information, go to Aimovig.com or<br/>call 1-800-77-AMGEN (1-800-772-6436).</paragraph>
                  <paragraph>CAUTION, Prior to use,<br/>read the enclosed<br/>Instructions for Use for <br/>administration information<br/>and see package insert for<br/> full Prescribing<br/>Information</paragraph>
                  <paragraph>Do Not Reuse</paragraph>
                  <paragraph>Not made with<br/>natural rubber latex</paragraph>
                  <renderMultiMedia referencedObject="MM74"/>
               </text>
               <effectiveTime value="20250331"/>
               <component>
                  <observationMedia ID="MM74">
                     <text>PRINCIPAL DISPLAY PANEL - 70 mg/mL Syringe Carton</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-74.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="d3d9e2a1-a87c-46bc-8d21-c920a2175d00"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 70 mg/mL Autoinjector Carton</title>
               <text>
                  <paragraph>AMGEN</paragraph>
                  <paragraph>1 x 70 mg/mL Prefilled Autoinjector <br/>NDC 55513-841-01<br/> Rx Only</paragraph>
                  <paragraph>aimovig<sup>®</sup>
                     <br/>(erenumab-aooe)<br/> Injection</paragraph>
                  <paragraph>70<br/> mg/mL</paragraph>
                  <paragraph>70 mg/mL</paragraph>
                  <paragraph>Prefilled Autoinjector</paragraph>
                  <paragraph>For Subcutaneous Use Only</paragraph>
                  <paragraph>Store refrigerated at 2°C to 8°C (36°F to 46°F) in original <br/>carton to protect from light. Do Not Freeze. Do Not Shake.<br/> Discard Any Unused Portion.</paragraph>
                  <paragraph>Keep out of the sight and reach of children.</paragraph>
                  <paragraph>For more information, go to Aimovig.com or<br/> call 1-800-77-AMGEN (1-800-772-6436).</paragraph>
                  <paragraph>CAUTION, Consult<br/> Accompanying Documents</paragraph>
                  <paragraph>Do Not Reuse</paragraph>
                  <paragraph>No U.S. standard of potency</paragraph>
                  <paragraph>Aimovig.com/demo</paragraph>
                  <renderMultiMedia referencedObject="MM75"/>
               </text>
               <effectiveTime value="20250331"/>
               <component>
                  <observationMedia ID="MM75">
                     <text>PRINCIPAL DISPLAY PANEL - 70 mg/mL Autoinjector Carton</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-75.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="f79390d3-972c-4b81-ab19-5a9f6dd35fd6"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 70 mg/mL Autoinjector Carton - Sample</title>
               <text>
                  <paragraph>AMGEN</paragraph>
                  <paragraph>1 x 70 mg/mL Prefilled Autoinjector <br/>NDC 55513-841-00<br/> Rx Only</paragraph>
                  <paragraph>aimovig<sup>®</sup>
                     <br/>(erenumab-aooe)<br/> Injection</paragraph>
                  <paragraph>Not for Sale</paragraph>
                  <paragraph>70<br/> mg/mL</paragraph>
                  <paragraph>70 mg/mL</paragraph>
                  <paragraph>Prefilled Autoinjector</paragraph>
                  <paragraph>For Subcutaneous Use Only</paragraph>
                  <paragraph>Store refrigerated at 2°C to 8°C (36°F to 46°F) in original <br/>carton to protect from light. Do Not Freeze. Do Not Shake.<br/> Discard Any Unused Portion.</paragraph>
                  <paragraph>Keep out of the sight and reach of children.</paragraph>
                  <paragraph>For more information, go to Aimovig.com or<br/> call 1-800-77-AMGEN (1-800-772-6436)</paragraph>
                  <paragraph>CAUTION, Consult<br/> Accompanying Documents</paragraph>
                  <paragraph>Do Not Reuse</paragraph>
                  <paragraph>No U.S. standard of potency</paragraph>
                  <paragraph>Aimovig.com/demo</paragraph>
                  <renderMultiMedia referencedObject="MM76"/>
               </text>
               <effectiveTime value="20250331"/>
               <component>
                  <observationMedia ID="MM76">
                     <text>PRINCIPAL DISPLAY PANEL - 70 mg/mL Autoinjector Carton - Sample</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-76.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="27377853-f571-4179-a4ab-eabb7e1b06f1"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 140 mg/mL Autoinjector Carton</title>
               <text>
                  <paragraph>AMGEN</paragraph>
                  <paragraph>1 x 140 mg/mL Prefilled Autoinjector <br/> NDC 55513-843-01<br/> Rx Only</paragraph>
                  <paragraph>aimovig<sup>®</sup>
                     <br/>(erenumab-aooe)<br/> Injection</paragraph>
                  <paragraph>140<br/> mg/mL <br/>=<br/> 1<br/> dose</paragraph>
                  <paragraph>140 mg/mL</paragraph>
                  <paragraph>Prefilled Autoinjector</paragraph>
                  <paragraph>For Subcutaneous Use Only</paragraph>
                  <paragraph>Store refrigerated at 2°C to 8°C (36°F to 46°F) in <br/>original carton to protect from light. Do Not Freeze. <br/>Do Not Shake. Discard Any Unused Portion.</paragraph>
                  <paragraph>Keep out of the sight and reach of children.</paragraph>
                  <paragraph>For more information, go to Aimovig.com or<br/>call 1-800-77-AMGEN (1-800-772-6436).</paragraph>
                  <paragraph>CAUTION, Consult<br/>Accompanying Documents</paragraph>
                  <paragraph>Do Not Reuse</paragraph>
                  <paragraph>No U.S. standard of potency</paragraph>
                  <paragraph>Aimovig.com/demo</paragraph>
                  <renderMultiMedia referencedObject="MM77"/>
               </text>
               <effectiveTime value="20250331"/>
               <component>
                  <observationMedia ID="MM77">
                     <text>PRINCIPAL DISPLAY PANEL - 140 mg/mL Autoinjector Carton</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-77.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="7a62b003-c92d-41d3-8a1d-65a7dddcd440"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 140 mg/mL Autoinjector Carton - Sample</title>
               <text>
                  <paragraph>AMGEN</paragraph>
                  <paragraph>1 x 140 mg/mL Prefilled Autoinjector <br/> NDC 55513-843-00<br/> Rx Only</paragraph>
                  <paragraph>aimovig<sup>®</sup>
                     <br/>(erenumab-aooe)<br/> Injection</paragraph>
                  <paragraph>Not for Sale</paragraph>
                  <paragraph>140<br/> mg/mL <br/>=<br/> 1<br/> dose</paragraph>
                  <paragraph>140 mg/mL</paragraph>
                  <paragraph>Prefilled Autoinjector</paragraph>
                  <paragraph>For Subcutaneous Use Only</paragraph>
                  <paragraph>Store refrigerated at 2°C to 8°C (36°F to 46°F) in <br/>original carton to protect from light. Do Not Freeze. <br/>Do Not Shake. Discard Any Unused Portion.</paragraph>
                  <paragraph>Keep out of the sight and reach of children.</paragraph>
                  <paragraph>For more information, go to Aimovig.com or<br/>call 1-800-77-AMGEN (1-800-772-6436).</paragraph>
                  <paragraph>CAUTION, Consult<br/>Accompanying Documents</paragraph>
                  <paragraph>Do Not Reuse</paragraph>
                  <paragraph>No U.S. standard of potency</paragraph>
                  <paragraph>Aimovig.com/demo</paragraph>
                  <renderMultiMedia referencedObject="MM78"/>
               </text>
               <effectiveTime value="20250331"/>
               <component>
                  <observationMedia ID="MM78">
                     <text>PRINCIPAL DISPLAY PANEL - 140 mg/mL Autoinjector Carton - Sample</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-78.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="22185cd9-2879-4c72-800b-56e7e37946ef"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 140 mg/mL Syringe Carton</title>
               <text>
                  <paragraph>AMGEN<sup>®</sup>
                  </paragraph>
                  <paragraph>1 x 140 mg/mL Prefilled Syringe<br/>NDC 55513-842-01<br/>Rx Only</paragraph>
                  <paragraph>aimovig<sup>®</sup>
                     <br/>(erenumab-aooe)<br/>Injection</paragraph>
                  <paragraph>140<br/>mg/mL = 1<br/>dose</paragraph>
                  <paragraph>140 mg/mL</paragraph>
                  <paragraph>Single-dose Prefilled Syringe</paragraph>
                  <paragraph>For Subcutaneous Use Only</paragraph>
                  <paragraph>Store refrigerated at 2°C to 8°C (36°F to 46°F) in original <br/>carton to protect from light. Do Not Freeze. Do Not Shake.</paragraph>
                  <paragraph>Before injecting, allow AIMOVIG to sit at <br/>room temperature for at least 30 minutes<br/>with cap on, protected from direct sunlight.</paragraph>
                  <paragraph>Keep out of the sight and reach of children.</paragraph>
                  <paragraph>For more information, go to Aimovig.com or<br/>call 1-800-77-AMGEN (1-800-772-6436).</paragraph>
                  <paragraph>CAUTION, Prior to use,<br/>read the enclosed<br/>Instructions for Use for <br/>administration information<br/>and see package insert for<br/>full Prescribing Information</paragraph>
                  <paragraph>Do Not Reuse</paragraph>
                  <paragraph>Not made with<br/>natural rubber latex</paragraph>
                  <renderMultiMedia referencedObject="MM79"/>
               </text>
               <effectiveTime value="20250331"/>
               <component>
                  <observationMedia ID="MM79">
                     <text>PRINCIPAL DISPLAY PANEL - 140 mg/mL Syringe Carton</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="aimovig-79.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>